| Excerpt | Reference |
|---|
| "The acute pancreatitis is a disease which is unchangedly characterized by a high lethality." | ( Zastrow, R, 1979) |
| "Although acute pancreatitis is relatively common, factors useful in predicting immediate outcome or likelihood of recurrence have seldom been studied in greater detail." | ( Satiani, B; Stone, HH, 1979) |
| "Acute pancreatitis is discussed from the viewpoint of a medical intensive care unit, with particular reference to the early and late complications." | ( Kleinberger, G; Kotzaurek, R; Pall, H; Pichler, M; Raberger, G; Szeless, S, 1975) |
| "Macroamylasemia and acute pancreatitis are both associated with a high serum amylase." | ( Mark, LK; McCord, RG, 1977) |
| "It is concluded that acute pancreatitis is probably not rare in children with anticholinesterase insecticide poisoning." | ( Sofer, S; Weizman, Z, 1992) |
| "The pathogenesis of acute pancreatitis is based on the following principles: 1." | ( Klar, E, 1992) |
| "Acute pancreatitis is observed in patients with the acquired immunodeficiency syndrome (AIDS) (4-22%), and is reported with increasing frequency as a complication of therapy in human immunodeficiency virus-spectrum disease." | ( Greenfield, SM; Maxson, CJ; Turner, JL, 1992) |
| "Since acute pancreatitis is known to be associated with modification of the proteinase-antiproteinase equilibrium, we studied heparin cofactor II and antithrombin III as well as other biochemical and haematological parameters in 10 patients experiencing attacks of acute pancreatitis." | ( Aiach, M; Amiral, J; Bouillot, JL; Cambillau, M; Chadeuf, G; Sultan, Y; Toulon, P, 1991) |
| "The pathogenesis of acute pancreatitis is incompletely defined, but the outcome is determined in part by an acute inflammatory process." | ( Guice, KS; Kunkel, SL; Oldham, KT; Remick, DG; Ward, PA, 1991) |
| "Acute pancreatitis is a dreaded complication of biliary calculus disease, and several radiographic signs have been reported in association with this condition." | ( Alexander, HG; Buckner, AB; Shanley, DJ, 1991) |
| "Caerulein-induced acute pancreatitis is characterized by the occurrence of two membrane-bound vacuolar systems in acinar cells." | ( Adler, G; Bialek, R; Köhler, H; Willemer, S, 1990) |
| "The diagnosis of acute pancreatitis is still mainly based on the clinical signs and symptoms of the patients." | ( Lempinen, M; Schröder, T, 1986) |
| "Because acute pancreatitis is accompanied by multiple systemic manifestations and alterations of plasma membranes, the possibility that an abnormal translocation of calcium from extracellular to intracellular compartments could play a role in hypocalcemia of acute pancreatitis was investigated in dogs." | ( Bhattacharya, SK; Britt, LG; Crawford, AJ; Luther, RW; Moore, OF; Palmieri, GM; Pate, JW; Pitcock, JA, 1985) |
| "In most cases acute pancreatitis is associated with alcoholism or biliary tract disease." | ( Geokas, MC, 1972) |
| "Acute pancreatitis is associated with a significant decrease in pulmonary compliance (p less than 0." | ( Berry, AR; Davies, GC; Millar, AM; Taylor, TV, 1983) |
| "Acute pancreatitis is associated with damage to both the endocrine and exocrine pancreas." | ( Bobal, MA; Duckworth, WC; Iyer, R; Jallepalli, P; Solomon, SS, 1980) |
| "The pathogenesis of acute pancreatitis is poorly understood, despite well-recognised precipitating factors." | ( Jenkins, SA; Petersen, OH; Sutton, R; Ward, JB, 1995) |
| "Acute pancreatitis is an uncommon entity in patients infected with HIV." | ( Clotet, B; López, MP; Raventós, A; Romeu, J; Sirera, G; Veny, A, 1995) |
| "Acute pancreatitis is unusual in pediatric patients, and chronic pancreatitis is even less common." | ( Caulfield, M; Kay, M; Mathew, P; Steffen, R; Wyllie, R, 1994) |
| "Acute pancreatitis is thought to be quite uncommon in patients with systemic lupus erythematosus (SLE), especially if it is the initial manifestation of the disease." | ( Chen, CY; Huang, CC; Huang, JL; Hung, IJ, 1994) |
| "Fulminant acute pancreatitis is a disease of complex origin that results in activation of several of the proinflammatory cytokines." | ( Fabri, PJ; Franz, M; Gower, WR; Messina, J; Norman, J; Riker, A; Rosemurgy, AS, 1995) |
| "Acute pancreatitis is not an uncommon complication of OLT." | ( Camargo, CA; Clavien, PA; Greig, PD; Levy, GA, 1995) |
| "Acute pancreatitis is one of the noted causes of multiple organ failure but the mechanism by which local inflammation progresses to systemic disease is unknown." | ( Hayashida, H; Kato, T; Matsuura, N; Mori, T; Murata, A; Tanaka, N; Toda, H; Uda, K, 1995) |
| "Acute pancreatitis is an adverse effect of the treatment with antimonial drugs which is infrequently described in patients with HIV infection and visceral leishmaniasis (VL)." | ( Cortés, E; Cucurull, E; de Otero, J; Ocaña, I; Pahissa, A; Ribera, E, 1995) |
| "Acute pancreatitis is usually due to alcohol ingestion or biliary tract disease, and unusual causes include trauma, metabolic diseases, or drugs." | ( Evans, RJ; Jordan, J; Krolikowski, FJ; Miranda, RN, 1995) |
| "Acute pancreatitis is an uncommon but serious complication of cancer chemotherapy." | ( Adamson, PC; Balis, FM; Blaney, SM; Izraeli, S, 1994) |
| "The diagnosis "acute pancreatitis" is a tentative clinical diagnosis." | ( Dressler, C; Franke, KP; Herzig, M, 1994) |
| "Severe acute pancreatitis is often complicated by intraperitoneal infection, resulting in multiple organ failure (MOF)." | ( Egami, H; Ikei, S; Misumi, M; Mori, K; Moriyasu, M; Ogawa, M; Sameshima, H; Yamaguchi, Y, 1993) |
| "While acute pancreatitis is a recognized complication of numerous drugs, cytarabine's role in causing this complication is controversial." | ( Byrd, JC; McBride, CE; Moses, FM; Robson, ME; Solimando, DA; Yavorski, RT, 1996) |
| "Acute pancreatitis is a rare, albeit severe, secondary effect of valproic acid which is probably due to an idiosyncratic reaction." | ( Bahamonde Carrasco, A; Morán Blanco, A; Olcoz Goñi, JL, 1996) |
| "Acute pancreatitis is characterized by hyperamylasemia, pancreatic edema, and the presence of activated digestive enzymes within the pancreas." | ( Grady, T; Kaiser, A; Saluja, A; Steer, M, 1996) |
| "Acute pancreatitis is associated with the development of pulmonary dysfunction in a number of patients." | ( Galloway, SW; Kingsnorth, AN, 1996) |
| "Acute pancreatitis is also associated with a reduction in pancreatic blood flow and evidence of free radical generation, similarly suggesting the possibility of ischaemia-reperfusion injury." | ( Ashley, SW; Kusske, AM; Lewis, MP; Reber, HA; Reber, PU; Toyama, MT, 1996) |
| "Severe, acute pancreatitis is commonly associated with a systemic illness which may result in multiple organ failure." | ( Baxter, JN; Imrie, CW; McKay, C, 1996) |
| "Acute pancreatitis is known to be often complicated by lung injury; however, the pathogenesis of lung injury in the early phase of acute pancreatitis remains unclear." | ( Anan, K; Horita, Y; Morisaki, T; Tanaka, M; Torisu, M; Tsukahara, Y, 1996) |
| "This model of acute pancreatitis is associated with evidence of acute lung injury, including sequestered neutrophils within the pulmonary microvasculature, increased microvascular permeability, and interstitial pulmonary edema." | ( Brown, GE; Hofbauer, B; Saluja, AK; Steer, ML; Yamaguchi, Y; Yamanaka, K, 1997) |
| "Idiopathic acute pancreatitis is common." | ( Gregor, JC; Marotta, PJ; Taves, DH, 1996) |
| "Acute pancreatitis is a disease where the trigger mechanisms of the inflammation and thus also the influence of cytokines are very closely associated and are therefore apparent." | ( Bartek, J; Grosmanová, T; Havlík, R; Král, V, 1997) |
| "Acute pancreatitis is a known, although rare, complication of mesalamine treatment." | ( Fernández, J; Feu, F; Navarro, S; Panés, J; Sala, M; Terés, J, 1997) |
| "The acute pancreatitis is still serious diagnostic and therapeutic problem." | ( Anasiewicz, A; Maciejewski, R; Madej, B; Radzikowska, E, 1997) |
| "Patients with severe acute pancreatitis are not an entirely homogeneous group but in terms of pathogenesis and complications of their disease they have much more in common with each other than the patients who are collected under the unifying diagnosis of 'sepsis'." | ( Manji, M; Neoptolemos, JP; Wilson, PG, 1998) |
| "Acute pancreatitis is associated with passage of gallstones, although the mechanism(s) linking the two processes remains undefined." | ( Alvarez, C; Bass, BL; Fasano, A, 1998) |
| "Acute pancreatitis is a rather common abdominal disorder." | ( Haapiainen, RK; Hedström, JI; Kemppainen, EA; Puolakkainen, PA; Stenman, UH, 1998) |
| "The severity of acute pancreatitis is independent of the elevation in serum amylase/lipase level (3n) on admission." | ( Burchard-Reckert, S; Lankisch, PG; Lehnick, D, 1999) |
| "The rabbit models of acute pancreatitis are reliable in that enzymatic and histological evidence of acute pancreatitis with or without systemic complications developed." | ( Deleuran, B; Jakobsen, NO; Jensen, SL; Kristensen, JU; Larsen, CG; Lausten, SB; Osman, MO, 1999) |
| "Acute pancreatitis is a clinical condition that develops when active pancreatic inflammation is induced by stimuli noxious to the pancreas." | ( Dassopoulos, T; Ehrenpreis, ED, 1999) |
| "Acute pancreatitis is a serious complication of endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic sphincterectomy (EST)." | ( Bekavac-Beslin, M; Duvnjak, M; Hrabar, D; Simicević, VN; Smircić-Duvnjak, L; Supanc, V; Troskot, B, 1999) |
| "Acute pancreatitis is a disorder that has numerous causes and an obscure pathogenesis." | ( Sakorafas, GH; Tsiotou, AG, 2000) |
| "Acute pancreatitis is a common, often severe disease with multiple causes." | ( Neoptolemos, JP; Petersen, OH; Raraty, MG; Sutton, R, 1999) |
| "Because severe acute pancreatitis is characterized by the development of systemic inflammation the authors studied whether procalcitonin, a marker of systemic inflammation, differentiated between patients with mild and severe acute pancreatitis." | ( Haapiainen, R; Kemppainen, E; Kylänpää-Bäck, ML; Puolakkainen, P; Repo, H; Takala, A, 2001) |
| "Acute pancreatitis is a rarely reported adverse effect." | ( Bakirtaç, A; Kara, C; Kuyucu, N; Teziç, T, 2001) |
| "Acute pancreatitis is the most frequent and difficult-to-avoid complication of endoscopic retrograde cholangiopancreatography (ERCP)." | ( Budzyńska, A; Kaczor, R; Marek, T; Nowak, A; Nowakowska-Dulawa, E, 2001) |
| "Acute pancreatitis is a known complication of cardiac surgery with cardiopulmonary bypass but amylase is not a reliable marker in infants." | ( Andersén, MJ; Hedström, J; Leijala, M; Rautiainen, P; Stenman, UH; Tikanoja, T, 2002) |
| "Acute pancreatitis is a common disorder." | ( Fukui, T; Morimoto, T; Noguchi, Y; Sakai, T; Shimbo, T, 2002) |
| "Acute pancreatitis is accompanied by the enhanced expression of EGF in the pancreas and the administration of EGF was found to exhibit the beneficial effect on edematous cerulein-induced pancreatitis." | ( Ceranowicz, P; Dembiński, A; Konturek, SJ; Stachura, J; Tomaszewska, R; Warzecha, Z, 2002) |
| "Prognosis of acute pancreatitis is related mainly to systemic involvement." | ( Alvarez-Mon, M; Belmonte, A; Caro-Patón, A; del Olmo, ML; Manzano, L; Mozo, G; Reyes, E, 2002) |
| "VPA-coincident acute pancreatitis is uncommon and idiosyncratic." | ( Deaton, R; Pellock, JM; Sommerville, KW; Wilder, BJ, 2002) |
| "Acute pancreatitis is one of the major complications of ERCP." | ( Baillie, J; Sultan, S, 2002) |
| "Acute pancreatitis is an inflammatory disease characterized by pancreatic tissue edema, acinar cell necrosis, hemorrhage and inflammation of the damaged gland." | ( Che, CT; Ip, SP; Leung, PS; Tsang, SW; Wong, TP, 2003) |
| "Mortality in acute pancreatitis is still substantial." | ( Andersson, R; Andrén-Sandberg, A, 2003) |
| "Severe acute pancreatitis is occasionally associated with pancreatic and intestinal necrosis." | ( Hirota, M; Inoue, K; Kimura, Y; Kuwata, K; Ogawa, M; Ohmuraya, M, 2003) |
| "Acute pancreatitis is an inflammatory process of variable severity, and leukocytes are thought to play a key role in the development of pancreatitis and pancreatitis-associated lung injury." | ( Frossard, JL; Hadengue, A; Jordan, M; Morel, P; Pastor, CM; Rubbia-Brandt, L, 2003) |
| "Acute pancreatitis is rarely included as a cause of abdominal pain in patients with sickle cell disease." | ( Ahmed, S; Kimpo, M; Mattana, J; Russo, L; Siddiqui, AK; Siddiqui, RK, 2003) |
| "Severe acute pancreatitis is associated with a high mortality, especially when compared with mild acute pancreatitis." | ( Bank, S; Indaram, A; Pooran, N; Singh, P, 2003) |
| "Severe acute pancreatitis is associated with an early increase in intestinal permeability and endotoxemia." | ( Ammori, BJ; Barclay, GR; Becker, KL; Kite, P; Larvin, M; McMahon, MJ; Nylén, ES; Snider, RH; White, JC, 2003) |
| "80% of all cases of acute pancreatitis are etiologically correlated to diseases of the biliary tract or an excess alcohol consumption." | ( Kraft, M; Lerch, MM; Mayerle, J; Meister, T; Simon, P, 2003) |
| "Acute pancreatitis is an important and fatal disease with high mortality and morbidity." | ( Deveci, S; Gorgulu, S; Kaymakcioglu, N; Ozcelik, H; Serdar, M; Simsek, A; Tufan, T; Yagci, G; Zeybek, N, 2003) |
| "Although acute pancreatitis is not infrequent after organophosphate intoxication, it is quite rare after carbamate ingestion and has not been previously reported after carbofuran intoxication." | ( Efremidis, S; Elisaf, M; Kosta, P; Liberopoulos, E; Rizos, E, 2004) |
| "Acute pancreatitis is a multifactorial disease caused by activation of several inflammatory mediators." | ( Batur, Y; Celik, HA; Musoglu, A; Oruc, N; Ozutemiz, AO; Yuce, G; Yukselen, V, 2004) |
| "Acute pancreatitis is a severe disease with considerable morbidity and mortality." | ( de Oliveira Júnior, HP; Malbergier, A, 2004) |
| "Acute pancreatitis is a reversible process, whereas chronic pancreatitis produces irreversible changes in the architecture and function of the pancreas." | ( Lowe, ME, 2004) |
| "Acute pancreatitis is a rare complication of interferon (IFN) and ribavirin (RBV) therapy." | ( Anand, BS; Batash, S; Bini, EJ; Chaudhari, S; Dieterich, DT; Park, J; Pimstone, NR, 2004) |
| "Acute pancreatitis is related to drugs in 1." | ( Franciosi, C; Perego, E; Romano, F; Scaini, A; Uggeri, F, 2004) |
| "Acute pancreatitis is rarely seen when azathioprine is used for other diseases than Crohn's disease." | ( Homan van der Heide, JJ; Jansen, PL; Oostenbrug, LE; Peters, FT; Ploeg, RJ; Posthumus, MD; van den Berg, AP; van Dullemen, HM; van Haastert, M; Weersma, RK, 2004) |
| "Acute pancreatitis is strongly associated with Crohn's disease and rarely occurs with other underlying conditions." | ( Homan van der Heide, JJ; Jansen, PL; Oostenbrug, LE; Peters, FT; Ploeg, RJ; Posthumus, MD; van den Berg, AP; van Dullemen, HM; van Haastert, M; Weersma, RK, 2004) |
| "Serious acute pancreatitis is frequently complicated by infections." | ( Bruno, MJ; de Vos, AF; Florquin, S; Schultz, MJ; van der Poll, T; van Westerloo, DJ, 2004) |
| "Hypertriglyceridemic acute pancreatitis is relapsing and its clinical course is more severe than lithiasic acute pancreatitis." | ( Cubiella, J; Fernández-Cruz, L; Feu, F; Navarro, S; Ros, E; Zambón, D, 2004) |
| "Acute pancreatitis is a disease with a wide variety of pathophysiologies, ranging from mild to severe condition." | ( Hirata, K, 2004) |
| "Acute pancreatitis is not uncommon after organophosphate intoxication and carbamates share the same risk as organophosphorus pesticides." | ( Achillews, G; Christodoulides, P; Ioannides, M; Koukouvas, M; Makrides, C; Symeonides, M; Tsikkos, S; Vounou, E, 2005) |
| "Acute pancreatitis is a severe complication of gallstones with considerable mortality." | ( Broeders, IA; Go, PM; Rehfeld, JF; Renooij, W; van Erpecum, KJ; VanBerge-Henegouwen, GP; Venneman, NG, 2005) |
| "Acute pancreatitis is viewed as an event and chronic pancreatitis as a process, sequentially linked, reflecting a complex interaction between genetic and environmental factors." | ( Grigorescu, M; Grigorescu, MD, 2005) |
| "Acute pancreatitis is an auto-digestive disease resulting in inflammation." | ( De Lisle, RC, 2005) |
| "Drug-induced acute pancreatitis is a rather rare clinical entity." | ( Antonopoulos, S; Filioti, K; Giannoulis, G; Karamanolis, D; Kokkoris, S; Mikros, S; Protopsaltis, J, 2005) |
| "Acute pancreatitis is a frequently reported consequence of organophosphate poisoning, but preventing this potentially severe complication has not been the subject of much research." | ( Avsaroğullari, L; Ikizceli, I; Kucuk, C; Muhtaroglu, S; Soyuer, I; Sozuer, EM; Yavuz, Y; Yurumez, Y, 2005) |
| "An acute pancreatitis is relatively common after intravenous administration." | ( Jeremić, Lj; Jovanović, M; Karadzić, D; Madić, J; Stanojević, G; Stojanović, M; Zivanović, D, 2004) |
| "Acute pancreatitis is an inflammatory disorder, and inflammation not only affects the pathogenesis but also the course of the disease." | ( Bhatia, M, 2005) |
| "Acute pancreatitis is a common digestive disease of which the severity may vary from mild, edematous to severe, necrotizing disease." | ( Kemppainen, E; Lempinen, M; Puolakkainen, P, 2005) |
| "Acute pancreatitis is characterized by the pathologic activation of zymogens within pancreatic acinar cells." | ( Gorelick, FS; Grant, WM; Husain, SZ; Kolodecik, TR; Nathanson, MH; Prasad, P, 2005) |
| "Acute pancreatitis is a clinical condition whose incidence has increased over the past few years." | ( Bhatia, M; Hegde, A, 2005) |
| "The developing of acute pancreatitis is a serious adverse effect following insecticide intoxication and is better known with dichlorvos than methomyl." | ( Abidi, N; Amamou, M; Blel, Y; Brahmi, N; Kouraichi, N; Thabet, H, 2005) |
| "When acute pancreatitis is suspected, chest and abdominal X-ray examinations should be performed to determine whether any abnormal findings caused by acute pancreatitis are present." | ( Hirata, K; Hirota, M; Isaji, S; Kawarada, Y; Kimura, Y; Koizumi, M; Matsuno, S; Mayumi, T; Otsuki, M; Sekimoto, M; Takada, T; Takeda, K; Yoshida, M, 2006) |
| "Acute pancreatitis is generally believed to be a disease in which the pancreas is injured by digestive enzymes that it normally produces." | ( Perides, G; Steer, ML; van Acker, GJ, 2006) |
| "Acute pancreatitis is one of the complications after Endoscopic retrograde cholangio pancreatography (ERCP) and it could be fatal." | ( Kwanngern, K; Navicharern, P; Tiyapattanaputi, P; Wanitpukdeedecha, M, 2005) |
| "Acute pancreatitis is a reversible event involving diffuse inflammation of the pancreas with variable involvement of other regional tissues, remote organs, or both, whereas chronic pancreatitis is a process that produces irreversible changes in the pancreatic structure and function." | ( Kandula, L; Lowe, ME; Whitcomb, DC, 2006) |
| "Acute pancreatitis is a disease involving pro-inflammatory mediators." | ( Dobosz, M; Dobrowolski, S; Gruca, Z; Hac, S; Kaczor, JJ; Krajewski, J; Rzepko, R; Sledzinski, Z, 2006) |
| "Acute pancreatitis is a common, and as yet incurable, clinical condition, the incidence of which has been increasing over recent years." | ( Bhatia, M; Hegde, A, 2007) |
| "Acute pancreatitis is associated with premature zymogen activation and a blockage in digestive enzyme secretion." | ( Bhagat, L; Dawra, RK; Navina, S; Saluja, AK; Sharif, R; Singh, VP, 2007) |
| "The pathogenesis of acute pancreatitis is not fully understood." | ( Dawra, R; Dhaulakhandi, D; Dudeja, V; Phillips, P; Saluja, AK; Sharif, R, 2007) |
| "Severe acute pancreatitis is characterized by lipase-induced peripancreatic fat cell necrosis." | ( Büchler, C; Fürst, A; Herfarth, H; Landfried, K; Schäffler, A; Schölmerich, J; Völk, M, 2007) |
| "Acute pancreatitis is a common complication of endoscopic retrograde cholangiopancreatography and the benefit of its pharmacological treatment is unclear." | ( Chen, Y; Li, J; Yang, X; Zeng, Q; Zhang, Y; Zheng, M, 2007) |
| "Acute pancreatitis is rarely seen in children, and, in contrast to cases in adults, it is often drug induced." | ( Bell, N; Bettendorf, U; Brockmann, K; Büsing, D; Eckel, U; Gerstner, T; Hanefeld, F; Hebing, B; Hoffmann, R; Kasper, JM; Klostermann, W; König, S; Longin, E; Neumann, FW; Sandrieser, T; Weidner, B; Wiemer-Kruel, A; Wolff, M, 2007) |
| "Acute pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP)." | ( Ainechi, S; Khatibian, M; Kolahdoozan, S; Malboosbaf, R; Nouraie, M; Sotoudehmanesh, R, 2007) |
| "Acute pancreatitis is an autodigestive disease, in which the pancreatic tissue is damaged by the digestive enzymes produced by the acinar cells." | ( Alhonen, L; Hyvönen, MT; Jänne, J; Keinänen, TA; Merentie, M; Uimari, A, 2007) |
| "Acute pancreatitis is a rare complication during chemotherapy for pediatric patients with solid tumors." | ( Hung, GY; Hung, MC; Lin, PC; Tien, YC; Tiu, CM, 2007) |
| "Acute pancreatitis is an important cause of morbidity and mortality, mainly due to sepsis." | ( Bourgaux, JF; Defez, C; Muller, L; Navarro, F; Pouderoux, P; Prudhomme, M; Sotto, A; Vivancos, J, 2007) |
| "In humans, acute pancreatitis is associated with up-regulation of ligands as well as receptors of the endocannabinoid system in the pancreas." | ( Agarwal, N; Bátkai, S; Bergmann, F; Friess, H; Giese, NA; Giese, T; Kuner, R; Laukert, T; Michalski, CW; Pacher, P; Sauliunaite, D; Su, Y, 2007) |
| "Acute pancreatitis is a pancreatic inflammation that recognises Salmonella typhi among its aetiological agents." | ( Bertuccio, SN; Rombolà, F, 2007) |
| "Acute pancreatitis is a disease caused by gallstones in 40-60% of patients." | ( Alexakis, N; Evans, J; Garvey, C; Ghaneh, P; Gilmore, I; Hughes, M; Lombard, M; Neoptolemos, JP; Raraty, M; Smart, HL; Sutton, R, 2007) |
| "Acute pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP)." | ( Draganov, PV; Lieb, JG, 2007) |
| "Acute pancreatitis is an inflammatory disease of the pancreas which, in its most severe form, is associated with multi-organ failure and death." | ( Hegyi, P; McCarroll, J; Rakonczay, Z; Saluja, AK; Takács, T, 2008) |
| "However, acute pancreatitis is rare." | ( Bhalla, A; Bhardwaj, U; Gill, K; Singh, S; Verma, SK, 2007) |
| "Despite this, acute pancreatitis is a rarely reported adverse effect of cannabis use." | ( Geveden, BN; McConnell, VJ; Wargo, KA, 2007) |
| "Acute pancreatitis is rarely seen in children, and it is often drug induced." | ( Köse, G; Ozaydin, E; Yükselgüngör, H, 2008) |
| "Acute pancreatitis is an inflammatory disease of the pancreas." | ( Frossard, JL; Pastor, CM; Steer, ML, 2008) |
| "In addition, acute pancreatitis is one of the extra-intestinal manifestations of acute exacerbation of CD without the previous use of azathioprine." | ( Koren, M; Potrc, S; Sinkovic, A; Skok, P, 2008) |
| "Acute pancreatitis is an inflammatory disease characterized by local tissue injury and systemic inflammatory response leading to massive nitric oxide (NO) production and haemodynamic disturbances." | ( Antunes, E; Camargo, EA; Delbin, MA; Ferreira, T; Landucci, EC; Zanesco, A, 2008) |
| "AZA-induced acute pancreatitis is always mild." | ( Algaba, A; Bermejo, F; Calvo, M; Carneros, JA; Gisbert, JP; López, P; Lopez-Sanroman, A; Luna, M; Martín-Arranz, MD; Menchén, L; Mendoza, JL; Opio, V; Pérez-Calle, JL; Taxonera, C; Van-Domselaar, M; Vera, I, 2008) |
| "Acute pancreatitis is a serious disease with fatality rate up to 15%." | ( Choi, HS; Hahm, JS; Han, DS; Joo, YW; Lee, HL; Lee, OY; Son, CN; Yoon, BC, 2008) |
| "Acute pancreatitis is one such rare gastrointestinal manifestation of acute pancreatitis." | ( Antony, T; Baburaj, P; Harikrishnan, BL; Louis, F, 2008) |
| "Because acute pancreatitis is a severe inflammatory disease, we hypothesized that AT III would inhibit inflammation and prevent cerulein-induced acute pancreatitis." | ( Hagiwara, S; Iwasaka, H; Matsumoto, S; Noguchi, T; Shingu, C; Uchida, T, 2009) |
| "Drug-induced acute pancreatitis is rare but should not be overlooked in a patient who presents with idiopathic acute pancreatitis." | ( Igarashi, H; Ito, T; Oono, T; Sakai, H; Takayanagi, R; Yoshinaga, M, 2009) |
| "Drug-induced acute pancreatitis is often challenging for clinicians and a detailed mechanism is unknown." | ( Igarashi, H; Ito, T; Oono, T; Sakai, H; Takayanagi, R; Yoshinaga, M, 2009) |
| "Acute pancreatitis is an inflammatory disease characterized by local tissue injury which can trigger a systemic inflammatory response." | ( Thachil, J, 2009) |
| "Acute pancreatitis is characterized by an activation cascade of digestive enzymes in the pancreas." | ( Aghdassi, A; Dummer, A; Halangk, W; Kähne, T; Kruse, A; Lerch, MM; Lippert, H; Matthias, R; Mayerle, J; Peters, C; Reinheckel, T; Ruthenbürger, M; Sahin-Tóth, M; Schulz, HU; Sendler, M; Teller, S; Wartmann, T; Weiss, FU, 2010) |
| "Severe acute pancreatitis is a life threatening disease with a high rate of mortality, and its treatments are still controversial." | ( Dong, X; Gao, SL; Jiang, RY; Peng, JP; Wang, J; Wu, YL; Xie, QP; Zhan, YC, 2010) |
| "When acute pancreatitis is suspected in patients with acute onset of abdominal pain and tenderness mainly in the upper abdomen, the diagnosis of acute pancreatitis is made on the basis of elevated levels of pancreatic enzymes in the blood and/or urine." | ( Amano, H; Arata, S; Gabata, T; Hattori, T; Hirata, K; Hirota, M; Kadoya, M; Kimura, Y; Kiriyama, S; Mayumi, T; Sekimoto, M; Takada, T; Takeda, K; Wada, K; Yamanouchi, E; Yokoe, M; Yoshida, M, 2010) |
| "Severe acute pancreatitis is associated with a typical systemic inflammatory response syndrome and over-expression of pro-inflammatory cytokines [interleukin (IL)-6, IL-8, macrophage migration inhibitory factor (MIF)]." | ( Barauskas, G; Berberat, PO; Dambrauskas, Z; Friess, H; Giese, N; Giese, T; Gulbinas, A; Pundzius, J, 2010) |
| "Acute pancreatitis is an inflammatory disease of the pancreas caused by release of activated digestive enzymes in the pancreas." | ( Khanduja, KL; Malhotra, S; Pandhi, P; Sidhu, S; Vaiphei, K, 2011) |
| "Acute pancreatitis is a painful, inflammatory disorder for which adequate treatments are lacking." | ( Ahmad, MU; Bhandari, V; Choo-Wing, R; Husain, SZ; Jain, D; Orabi, AI; Parness, J; Shah, AU, 2010) |
| "Acute pancreatitis is a necroinflammatory disease that leads to 210,000 hospitalizations in the United States annually." | ( Ahmad, MU; Bhandari, V; Bultron, G; Husain, SZ; Latif, SU; Orabi, AI; Park, AJ, 2010) |
| "Drug-induced acute pancreatitis is considered to be a rare diagnosis." | ( Procházka, M; Procházka, V; Urbánek, K; Vinklerová, I, 2010) |
| "Acute pancreatitis is an inflammatory disorder of the pancreas." | ( Bhatia, M; Ramnath, RD; Sun, J, 2010) |
| "Acute pancreatitis is diagnosed on the basis of clinical features, biochemical tests and imaging studies." | ( Baddoura, W; DiGiacomo, WS; Eddi, R; Kothari, ST; Maksoud, C; Shah, AM, 2010) |
| "Acute pancreatitis is an inflammatory disease of the pancreas, which can result in serious morbidity or death." | ( Farina, A; Fetaud-Lapierre, V; Frossard, JL; Hochstrasser, DF; Lescuyer, P; Pastor, CM, 2010) |
| "Acute pancreatitis is an autodigestive process resulting in acute inflammation of the pancreas." | ( Altavilla, D; Bitto, A; Fazzari, C; Irrera, N; Minutoli, L; Polito, F; Squadrito, F, 2010) |
| "Acute pancreatitis is commonly associated with severe abdominal pain, making early pain relief a primary goal of the treatment." | ( Meffert, KS; Schultes, B; Wilms, B, 2010) |
| "Severe acute pancreatitis is associated with high mortality with infectious complications being the most common cause of mortality." | ( Kochhar, R; Noor, MT; Radhakrishna, Y; Ray, P; Singh, K; Sinha, SK; Wig, JD, 2011) |
| "Acute pancreatitis is a common kind of acute abdominal disease." | ( Ma, Q; Ma, Z; Sha, H; Wang, Z; Zhang, M, 2011) |
| "Acute pancreatitis is an inflammatory condition that may lead to multisystemic organ failure." | ( Altavilla, D; Bitto, A; Fazzari, C; Giuliani, D; Guarini, S; Guzzo, G; Irrera, N; Macrì, A; Marini, H; Minutoli, L; Nicotina, PA; Ottani, A; Polito, F; Spaccapelo, L; Squadrito, F, 2011) |
| "Acute pancreatitis is an inflammatory process of variable severity." | ( Frossard, JL; Galan, K; Hadengue, A; Lenglet, S; Mach, F; Montecucco, F; Pelli, G; Spahr, L; Steffens, S, 2011) |
| "Acute pancreatitis is a substantial clinical problem accounting for 240,000 hospital admissions yearly in the United States." | ( Al-Azzawi, HH; Pitt, HA; Swartz-Basile, DA; Wade, TE; Wang, S; Zyromski, NJ, 2011) |
| "Acute pancreatitis is considered a relevant major complication following endoscopic retrograde cholangiopancreatography (ERCP); according to literature data, the incidence varies between 1." | ( Domagk, D; Domschke, W; Heinecke, A; Heinzow, H; Hoehr, R; Meister, T, 2011) |
| "The human disease acute pancreatitis is initiated by trypsinogen activation in the apical pole and this is mostly due to either complications arising from gall bladder stones or excessive alcohol consumption." | ( Gerasimenko, JV; Gerasimenko, OV; Petersen, OH; Tepikin, AV, 2011) |
| "Acute pancreatitis is a life-threatening inflammatory disease characterized by abdominal pain of unknown etiology." | ( Bunnett, NW; Cattaruzza, F; Ceppa, EP; Grady, EF; Grahn, S; Kirkwood, KS; Knecht, W; Lyo, V; Peterson, A, 2011) |
| "Acute pancreatitis is characterized by early activation of intracellular proteases followed by acinar cell death and inflammation." | ( Barrat, F; Flavell, R; Gorelick, F; Hoque, R; Husain, S; Luo, Y; Malik, A; Mehal, W; Sarwar, S; Shah, A; Sohail, M, 2011) |
| "Acute pancreatitis is a rare, but fatal, manifestation of systemic lupus erythematosus." | ( Alishiri, G; Bayat, N; Ghamarchehreh, ME; Khajehpoor, H; Nooranipour, M, 2011) |
| "Acute pancreatitis is a potentially fatal disease with no known cure." | ( Chu, PY; Deng, JF; Liu, MY; Srinivasan, P, 2012) |
| "MMI-induced acute pancreatitis is very rare, being described in only a few patients and never after more than two exposures as reported here." | ( Deng, HC; Qu, H; Yang, M, 2012) |
| "MMI-induced acute pancreatitis is rare and easily misdiagnosed." | ( Deng, HC; Qu, H; Yang, M, 2012) |
| "Acute pancreatitis is a common inflammatory disease mediated by damage to acinar cells and subsequent pancreatic inflammation with recruitment of leukocytes." | ( Ebinuma, H; Hibi, T; Hozawa, S; Kanai, T; Miyata, N; Nakamura, Y; Nakano, M; Ono, Y; Saeki, K; Sujino, T; Takaishi, H; Takeda, K; Yamagishi, Y; Yoshimura, A, 2012) |
| "Acute pancreatitis is a common complication of endoscopic retrograde cholangiopancreatography (ERCP)." | ( Akiyama, T; Ario, K; Fujimoto, M; Kamachi, S; Kawazoe, S; Nakashita, S; Noda, T; Oeda, S; Otsuka, T; Sumida, C; Tabuchi, M, 2012) |
| "Acute pancreatitis is a common disease, which is divided into mild pancreatitis and severe pancreatitis." | ( Gao, J; Han, W; Lu, H; Qian, L; Shen, J; Shen, Z; Wan, R; Wang, X, 2012) |
| "But acute pancreatitis is a very rare complication in falciparum malaria." | ( Chatterjee, SK; Das, BK; Guh, P; Mandal, B; Ray, A; Shai, S; Sharma, A, 2011) |
| "Severe acute pancreatitis is a disease with high mortality." | ( Chen, RJ; Hsieh, CH; Hsieh, YC; Liu, LC; Lu, CW; Yang, LH, 2013) |
| "Acute pancreatitis is a common complication of endoscopic retrograde cholangiopancreatography (ERCP)." | ( Draganov, PV; Yang, D, 2012) |
| "Acute pancreatitis is rare in pregnancy, with an estimated incidence of 1 in 1000-3000 pregnancies." | ( Brooks, H; Jacob, A; Pandey, R, 2012) |
| "Acute pancreatitis is the most common serious complication of endoscopic retrograde cholangio-pancreatography (ERCP) and its incidence may exceed 25% in some high-risk patient subsets." | ( Caruso, R; Monteleone, G; Pallone, F; Tammaro, S, 2012) |
| "Acute pancreatitis is one of the potentially lethal complications that occurs after cardiac surgery." | ( Chung, JB; Chung, JW; Jo, JH; Lee, S; Park, JY; Park, SW; Ryu, SH; Song, SY, 2013) |
| "Acute pancreatitis is the most common complication of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography (ERCP)." | ( Aghdassi, A; Büchner-Steudel, P; Budde, C; Czakó, L; Engel, G; Fluhr, G; Glitsch, A; Gress, T; Hegyi, P; Hoffmeister, A; Kantowski, M; Kohlmann, T; Kraft, M; Lerch, MM; Linhart, T; Maul, J; Mayerle, J; Mössner, J; Müller, M; Nitsche, C; Pickartz, T; Rösch, T; Rosendahl, J; Seufferlein, T; Siegmund, B; Simon, P; Stallmach, A; Storck, K; Weber, E; Zuber-Jerger, I, 2013) |
| "Acute pancreatitis is a severe clinical conditio that causes significant mortality in patients." | ( Ćwik, G; Dyndor, P; Maciejewski, R; Solecki, M; Wallner, G; Ziemiakowicz, R, 2013) |
| "Acute pancreatitis is an acute inflammatory process of the pancreas that may also involve adjacent tissues and/or remote organ systems." | ( Basurto Ona, X; Rigau Comas, D; Urrútia, G, 2013) |
| "Acute pancreatitis is a common disease." | ( Licul, V; Mijandrušić-Sinčić, B; Mikolašević, I; Milić, S; Štimac, D, 2013) |
| "Acute pancreatitis is a human disease in which the pancreatic pro-enzymes, packaged into the zymogen granules of acinar cells, become activated and cause autodigestion." | ( Gerasimenko, JV; Gerasimenko, OV; Petersen, OH, 2014) |
| "Acute pancreatitis is the most common complication of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography (ERCP)." | ( Ding, J; Jin, X; Li, Y; Liu, S; Pan, Y, 2013) |
| "Acute pancreatitis is a disease, which could be manifested as either a mild edematous form or a more severe necrotizing pancreatitis which has a poor prognosis." | ( Bonior, J; Jaworek, A; Jaworek, J; Kot, M; Leja-Szpak, A; Nawrot-Porbka, K; Szklarczyk, J, 2014) |
| "Acute pancreatitis is the most common adverse event of endoscopic retrograde cholangiopancreatography (ERCP)." | ( Asgari, AA; Eloubeidi, MA; Farsinejad, M; Khatibian, M; Sotoudehmanesh, R, 2014) |
| "Severe acute pancreatitis is a life-threatening disease with a high mortality; so far, no causal treatment is known." | ( Bachmann, K; Dupree, A; Freitag, M; Izbicki, JR; Koops, S; Lohalm, H; Mann, O; Strate, T; Tomkötter, L, 2014) |
| "Drug-induced acute pancreatitis is a rare condition in childhood, and information about the incidence of valproic acid-induced acute pancreatitis in the pediatric population is scarce." | ( Talvik, I; Talvik, T; Uibo, O; Veri, K, 2013) |
| "Acute pancreatitis is a systemic immunoinflammatory response to auto-digestion of the pancrease and peri-pancreatic organs." | ( Askari, G; Fallah, AA; Feizi, A; Jafari, T, 2015) |
| "Acute pancreatitis is one of the most common complications of endoscopic retrograde cholangiopancreatography (ERCP)." | ( Bao, JJ; Ding, H; Hu, C; Liu, XC; Mei, Q; Xu, JM; Zhao, XW, 2014) |
| "Acute pancreatitis is characterized by inflammatory processes affecting not only the pancreas, but also the lung." | ( Burger, F; Carbone, F; Dallegri, F; Frossard, JL; Galan, K; Gomes Quinderé, AL; Lenglet, S; Mach, F; Montecucco, F; Pelli, G; Proudfoot, AE; Vonlaufen, A; Vuilleumier, N, 2014) |
| "Acute pancreatitis is most commonly caused by gallstones or chronic alcohol use, and accounts for more than 200,000 hospital admissions annually." | ( Quinlan, JD, 2014) |
| "Acute pancreatitis is a nonbacterial disease of the pancreas." | ( Jaworek, J; Konturek, SJ, 2014) |
| "Acute pancreatitis is a rare complication of chemotherapy agents." | ( Mir, MA; Pandey, MK; Sivik, J; Talamo, G, 2016) |
| "Acute pancreatitis is an inflammatory process of the pancreatic gland that eventually may lead to a severe systemic inflammatory response." | ( Pereda, J; Pérez, S; Sabater, L; Sastre, J, 2015) |
| "Acute pancreatitis is an inflammatory disease caused by several factors such as viral infection, drugs, and diagnostic endoscopy." | ( Al-Malki, AL, 2015) |
| "Acute pancreatitis is the most common major complication after endoscopic retrograde cholangiopancreatography (ERCP)." | ( Alvarez-Villaseñor, Adel S; Ambriz-González, G; Andrade-Dávila, VF; Chávez-Tostado, M; Cortés-Flores, AO; Cortés-Lares, JA; Dávalos-Cobián, C; Fuentes-Orozco, C; García-Correa, J; García-Rentería, J; González-Ojeda, A; Macías-Amezcua, MD; Montaño-Loza, A; Rendón-Félix, J, 2015) |
| "Acute pancreatitis is a common complication of endoscopic retrograde cholangiopancreatography (ERCP)." | ( Cheon, YK; Choi, JS; Do, JH; Lee, TY; Oh, HC; Song, TJ, 2015) |
| "AZA-induced acute pancreatitis is a common adverse event in IBD patients, but in this study had a mild course in all patients." | ( Bokemeyer, B; Bündgens, B; Büning, J; Drabik, A; Helwig, U; Hüppe, D; Klugmann, T; Kruis, W; Maaser, C; Miehlke, S; Mohl, W; Siegmund, B; Stallmach, A; Teich, N; Weismüller, J, 2016) |
| "Acute pancreatitis is an inflammatory pancreatic disease that carries considerable morbidity and mortality." | ( Li, X; Li, Z; Lu, B; Yu, C; Yu, X; Zhu, H; Zhu, S, 2015) |
| "Acute pancreatitis is associated with acute lung injury." | ( Basios, N; Kotini, A; Lambropoulou, M; Lampropoulos, P; Papalois, A; Pitiakoudis, MK; Simopoulos, C; Tsaroucha, AK, 2016) |
| "Severe acute pancreatitis is an inflammatory disease of the pancreas with a high morbidity and mortality." | ( Bachmann, K; Bockhorn, M; Dupree, A; Erbes, J; Hinsch, A; Izbicki, JR; Mann, O; Tomkötter, L; Trepte, C, 2016) |
| "Acute pancreatitis is a relatively rare but potentially lethal complication after transarterial chemotherapy." | ( Chan, AC; Chan, SC; Cheung, TT; Chok, KSh; Lo, CM; Poon, RT; She, WH, 2016) |
| "Acute pancreatitis is an inflammatory process originated in the pancreas; however, it often leads to systemic complications that affect distant organs." | ( Bian, ZX; Guan, YF; Ku, CF; Lin, ZS; Shi, XK; Tsang, SW; Wang, HQ; Xiao, HT; Zhang, HJ, 2016) |
| "Acute pancreatitis is an inflammatory condition of the pancreas that is painful and at times deadly." | ( Aşıkoğlu, M; Ay Şenyiğit, Z; İlem-Özdemir, D; Karasulu, HY; Oruç, N; Özütemiz, Ö; Üstündağ-Okur, N, 2016) |
| "Acute pancreatitis is an uncommon complication of sorafenib treatment." | ( Cheng, KS; Chou, JW; Huang, CW, 2016) |
| "Acute pancreatitis is a rare complication of PEG-IFN-α administration." | ( Bae, WK; Choi, JW; Kim, JG; Kim, JW; Kim, KA; Lee, JS; Paik, WH; Song, TJ, 2016) |
| "Because acute pancreatitis is fatal complication and quitting the drug usually leads to complete cure." | ( Fujiwara, K; Imai, Y; Shintani, D; Yoshida, H, 2016) |
| "Acute pancreatitis is a relatively common and potentially fatal condition, but the presenting symptoms are non-specific and diagnosis relies largely on the measurement of amylase activity by the hospital clinical laboratory." | ( Bentham, A; Chapman, R; Khan, SA; Lin, Y; Liu, NJ; Philips, N; Stevens, MM; Tyreman, M, 2016) |
| "Acute pancreatitis is an acute inflammatory process of the pancreas that can trigger a systemic inflammatory response." | ( Herath, HM; Kulatunga, A, 2016) |
| "Acute pancreatitis is an inflammatory process that frequently involves peripancreatic tissues and remote organ systems." | ( Park, J; Song, R; Yu, D, 2016) |
| "Acute pancreatitis is an inflammatory process of the pancreas that can be mild to severe." | ( Adam, JP; Gauthier, P; Letarte, N, 2017) |
| "Acute pancreatitis is the most common adverse event of endoscopic retrograde cholangiopancreatography (ERCP)." | ( Ataseven, H; Biyik, M; Çifçi, S; Demir, A; Polat, İ; Uçar, E; Uçar, R, 2016) |
| "Icodextrin-induced acute pancreatitis is not well described." | ( Fogel, J; Franjul, R; Rubinstein, S; Surana, S, 2016) |
| "Background Acute pancreatitis is the most common complication after ERCP, occurring in about 4 % of the procedures." | ( Camargo, G; de Quadros Onófrio, F; Dos Santos, CEO; Lehmen, RL; Lima, JCP; Oba, D; Watte, G, 2017) |
| "While acute pancreatitis is among the differential diagnosis for elevated lipase levels, several other causes of elevated lipase levels have been identified including several reports Salmonella species as a causative agent." | ( Buchan, D; Dean, R; Gill, D, 2017) |
| "Acute pancreatitis is basically considered as activation of inactive proenzymes in the pancreas and digestion of the gland itself." | ( Oter, V; Ozgonul, A; Yalcin, M, 2016) |
| "Acute pancreatitis is a severe complication of endoscopic retrograde cholangiopancreatography (ERCP)." | ( Lu, N; Ren, Y; Wan, J; Xia, L; Zhu, Z, 2017) |
| "Acute pancreatitis is rare during pregnancy." | ( Dossou, FM; Gbessi, DG; Gnangnon, FHR; Hounkpatin, B; Kpossou, AR; Lawani, I; Noukpozounkou, B; Olory-Togbe, JL; Souaibou, YI, 2017) |
| "Acute pancreatitis is a rapid onset of inflammation of the pancreas causing mild to severe life threatening conditions [1, 2]." | ( Bhayana, V; Ismail, OZ, 2017) |
| "BACKGROUND Acute pancreatitis is an inflammatory condition of the pancreas characterized clinically by epigastric abdominal pain and elevated levels of pancreatic enzymes in the blood." | ( Ghatak, R; Kapadia, D; Kulairi, ZI; Masso, L, 2017) |
| "Acute pancreatitis is the largest contributor to diabetes of the exocrine pancreas." | ( Chand, SK; Pendharkar, SA; Petrov, MS; Singh, RG, 2018) |
| "Acute Pancreatitis is a substantial health care challenge with increasing incidence." | ( Bauer, J; Carroll, T; Dirmeier, A; Fantuzzi, G; Jung, B; Krett, N; Kunst, C; Pang, J; Papachristou, G; Staudacher, JJ; Whitcomb, DC; Wilson, A; Xia, Y; Yazici, C, 2017) |
| "Acute pancreatitis is a disease associated with inflammation and tissue damage." | ( Chung, SL; Date, K; Desir, GV; Gorelick, FS; Kolodecik, TR; Patel, V; Reed, AM; Shugrue, CA, 2017) |
| "Acute pancreatitis is a well-recognised complication of endoscopic procedures like endoscopic retrograde cholangiopancreatography but not oesophagogastroduodenoscopy (OGD)." | ( Nwafo, NA, 2017) |
| "Acute pancreatitis is a multifactorial disease associated with profound changes of the pancreas induced by release of digestive enzymes that lead to increase in proinflammatory cytokine production, excessive tissue necrosis, edema, and bleeding." | ( Bucio, L; Gomez-Quiroz, LE; Gutierrez-Ruiz, MC; Lazzarini-Lechuga, R; Marquardt, JU; Miranda, RU; Palestino-Dominguez, M; Pelaez-Luna, M; Perez-Aguilar, B; Rodriguez-Ochoa, I; Souza, V, 2018) |
| "Acute pancreatitis is rarely observed in Henoch-Schönlein purpura children and has no specific clinical features that differentiate it from abdominal manifestations of Henoch-Schönlein purpura." | ( Deng, F; Gui, M; Guo, Q; Hu, B; Lu, L; Ren, Z; Zhang, Q, 2018) |
| "Acute pancreatitis is an acute inflammation of the pancreas that varies in severity from mild to life threatening usually requiring hospitalization." | ( Chams, S; El Sayegh, S; Hamdon, M; Kumar, S; Tegeltija, V, 2018) |
| "Severe acute pancreatitis is a highly lethal disease caused by systemic inflammatory response syndrome, leading to multiple organ failure." | ( Adachi, N; Liu, K; Mori, S; Nishibori, M; Takahashi, H; Terao, K; Teshigawara, K; Wake, H, 2018) |
| "Acute pancreatitis is a human disease with multiple causes that leads to autodigestion of the pancreas." | ( Deng, M; Feng, S; Hu, Q; Huang, X; Lü, M; Luo, G; Wei, Q; Zhou, X, 2019) |
| "Acute pancreatitis is an inflammatory disorder of the pancreas that may precipitate due to various reasons such as chronic alcoholism, gall stone obstruction, and life style." | ( Bale, S; Godugu, C; Khurana, A; Tiruveedi, VL, 2018) |
| "When acute pancreatitis is observed after the initiation of MMI, drug-induced pancreatitis should be considered as the possible etiology." | ( Kikuchi, I; Miyamoto, K; Miyata, N; Tachikawa, N; Yoshimura, Y, 2019) |
| "Acute pancreatitis is accompanied by acinar cell damage releasing potential toll-like receptor 3 (TLR3) ligands." | ( Benitz, S; Esposito, I; Kleeff, J; Kong, B; Leinenkugel, G; Mayerle, J; Michalski, CW; Mihaljevic, C; Raulefs, S; Regel, I; Rieder, S; Schlitter, AM; Steiger, K, 2019) |
| "Acute pancreatitis is one of the first pathological processes where autophagy has been described in a human tissue." | ( Grasso, D; Ropolo, A; Vaccaro, MI, 2019) |
| "Acute pancreatitis is a life-threatening disease accompanied by systemic inflammatory response." | ( Gu, T; Wang, D; Xu, Y; Zhang, W; Zhu, M, 2019) |
| "Acute pancreatitis is a disease with high morbidity and mortality, despite all the advances in technology." | ( Aydın, H; Özer, B; Özer, SP; Özgül, H; Sarı, S; Tatar, C, 2019) |
| "Acute pancreatitis is a major adverse event of endoscopic retrograde cholangiopancreatography (ERCP)." | ( Akimoto, Y; Fujii, M; Harada, R; Hata, H; Kato, H; Kawai, Y; Matsubara, M; Ogawa, T; Okada, H; Takatani, M; Tomoda, T; Ueki, T; Wato, M, 2019) |
| "Acute pancreatitis is an inflammatory disorder of the pancreas, and its correct diagnosis is an area of interest for clinicians." | ( Chen, K; Jin, WW; Mou, YP; Qian, ZY; Wang, YY; Xu, XD; Zhang, W, 2019) |
| "Severe acute pancreatitis is associated with high morbidity and mortality." | ( Bachmann, K; Erbes, J; Gocht, A; Grupp, K; Havel, J; Izbicki, JR; Mann, O; Poppe, A; Trepte, C; Wodack, K, 2019) |
| "Acute pancreatitis is an uncommon complication that occurs in 0." | ( Adarsh, MB; Dhir, V; Dhooria, A; Dwivedi, P; Jain, S; Kakkar, N; Kumar, RR; Malhotra, S; Naidu, S; Sharma, A; Sharma, SK, 2019) |
| "Although acute pancreatitis is rare it is clinically important because this condition can be life threatening if not treated promptly." | ( Li, YF; Wei, MJ, 2019) |
| "Acute pancreatitis is a severe systemic disease triggered by a sterile inflammation and initial local tissue damage of the pancreas." | ( Carvalho, T; Heindl, M; Hoffmeister, A; Jentho, E; Lorenz, J; Mössner, J; Sommerer, I; Weis, S, 2019) |
| "BACKGROUND Acute pancreatitis is an inflammatory disease of the pancreas associated with high patient morbidity." | ( Li, DW; Liu, SC; Xiong, GF; Zheng, MB, 2019) |
| "Acute pancreatitis is an inflammatory process of the pancreas and a leading cause of hospitalization amongst gastrointestinal disorders." | ( Bachmann, K; Bonk, S; Gocht, A; Grupp, K; Izbicki, JR; Mann, O; Poppe, A; Reeh, M; Wodack, K, 2020) |
| "Acute pancreatitis is a rare complication of scrub typhus which can result in a marked elevation of serum lipase." | ( Ali, S; Bhargava, A; Rajeevan, R; Udyavara, R, 2019) |
| "Acute pancreatitis is a serious complication of endoscopic retrograde cholangiopancreatography (ERCP)." | ( Ali-Asgari, A; Amani, M; Bagheri, M; Delavari, A; Eloubeidi, MA; Keshtkar, A; Khatibian, M; Malekzadeh, R; Merat, S; Mohamadnejad, M; Nasseri-Moghaddam, S; Sadeghi, A; Sima, A; Sotoudehmanesh, R; Vahedi, H, 2019) |
| "Acute pancreatitis is an inflammatory process of the pancreatic gland that may lead to dysregulation of the trans-sulfuration pathway." | ( Corrales, F; Franco, L; Guerrero, L; López-Rodas, G; Martí-Andrés, P; Paradela, A; Pérez, S; Rius-Pérez, S; Sastre, J; Taléns-Visconti, R; Torres, L; Torres-Cuevas, I, 2020) |
| "Acute pancreatitis is the most common complication following ERCP." | ( El Mir, J; Harb, M; Makhoul, E, 2019) |
| "Acute pancreatitis is characterized by an early intracellular protease activation and invasion of leukocytes into the pancreas." | ( Aghdassi, AA; John, DS; Krüger, B; Lerch, MM; Mayerle, J; Sendler, M; Storck, C; van den Brandt, C; Weiss, FU, 2019) |
| "Acute pancreatitis is considered as one of the idiosyncratic adverse reactions to antiepileptic drugs." | ( Huang, W; Ren, X; Shen, F; Xing, B, 2019) |
| "Acute pancreatitis is commonly caused by gallstones or alcohol abuse." | ( Heydari, R; Khosravifar, M; Navabi, SJ; Navabi, SM, 2020) |
| "Acute pancreatitis is a rare adverse effect of systemic retinoids." | ( Bahtaoui, W; Chiheb, S; El Fetoiki, FZ; Hali, F, 2020) |
| "Acute pancreatitis is a serious condition with multi-factorial etiology." | ( Abdel Hafez, SMN; Abdel-Hakeem, EA; Abdel-Hamid, HA, 2020) |
| "Patients with acute pancreatitis are frequently treated with opioids, but their risk for ongoing use is not well known." | ( Ahmed, A; Freedman, SD; Kothari, DJ; Sheth, SG; Yakah, W, 2020) |
| "Acute pancreatitis is a disease in which tissues in and around the pancreas are autodigested by pancreatic digestive enzymes." | ( Hashimoto, D; Hirota, M; Ogawa, M; Ohmuraya, M; Sugita, H; Suyama, K, 2020) |
| "Acute pancreatitis is one of the most common causes of inpatient care among gastrointestinal conditions." | ( Shi, L; Zhang, D; Zhang, J, 2020) |
| "Acute pancreatitis is a rare but recognised complication of clozapine leading to termination of treatment." | ( Arias, AJ; Hanley, K; Kuforiji, J; Quattrone, D; Rodriguez, V; Shergill, SS; Whiskey, E, 2020) |
| "Severe acute pancreatitis is a serious disease, but its detailed mechanism has not yet been elucidated." | ( Fushida, S; Harada, S; Kinoshita, J; Makino, I; Miyashita, T; Nakamura, K; Nakanuma, S; Ninomiya, I; Ohta, T; Okamoto, K; Sakai, S; Tajima, H; Tokoro, T, 2020) |
| "Acute pancreatitis is uncommon in children and adolescents, and when it does occur, it is rarely fatal." | ( Hade, AL; Zumwalt, RE, 2020) |
| "Acute pancreatitis is the most frequent underlying disorder (54." | ( Betrains, A; Nijs, J; Rosseels, W; Van Mieghem, E; Vanderschueren, S, 2021) |
| "Acute pancreatitis is a major adverse event of endoscopic retrograde cholangiopancreatography (ERCP)." | ( Fujii, Y; Horiguchi, S; Kato, H; Matsumi, A; Matsumoto, K; Miyamoto, K; Okada, H; Saragai, Y; Tomoda, T; Tsutsumi, K; Uchida, D; Ueta, E; Yamazaki, T, 2021) |
| "Acute pancreatitis is an unpredictable and potentially lethal disease." | ( Besselink, MG; Boermeester, MA; Bouwense, SA; Boxhoorn, L; Bruno, MJ; van Santvoort, HC; Verdonk, RC; Voermans, RP, 2020) |
| "Acute pancreatitis is formed in Group 3 (n=16) via injection of Na-taurokolat in the common bile duct." | ( Ergücük, H; Gürsul, S; İflazoğlu, N; Işık, S; Kayaalp, C; Saraç, M, 2020) |
| "Acute pancreatitis is one of the rare complications that is reported with vemurafenib use." | ( Chung, SY; Ghiuzeli, CM; Shen, JG, 2020) |
| "Acute pancreatitis is an important complication of endoscopic retrograde cholangiography (ERC), occurring between 1-10% of patients." | ( Losada, HF; San Martin, PI; Silva, JA; Troncoso, AI, 2021) |
| "Acute pancreatitis is associated with activation of coagulation and there is a close relationship between coagulation and the severity of this disease." | ( Ceranowicz, P; Chmura, A; Cieszkowski, J; Galazka, K; Kusnierz-Cabala, B; Maduzia, D; Warzecha, Z, 2020) |
| "Acute pancreatitis is one of the main reasons for hospitalization, with an increasing incidence and associated non-negligible morbidity and mortality." | ( Cano Calderero, FX; Junquera Alonso, E; Seoane Blanco, L, 2021) |
| "Acute pancreatitis is a common inflammatory disease." | ( Bian, X; Li, X; Pan, N; Wu, W; Yu, W; Zhang, M, 2021) |
| "Acute pancreatitis is not common among patients with COVID-19." | ( Barkoudah, E; Jin, DX; Kumar, V; McNabb-Baltar, J; Souza, DAT, 2021) |
| "Acute pancreatitis is one of the leading causes of gastrointestinal disorder-related hospitalizations, yet its pathogenesis remains to be fully elucidated." | ( Cui, T; Guo, Y; He, J; Hu, W; Li, C; Liu, R; Wang, X; Yin, C, 2021) |
| "Acute pancreatitis is a common inflammatory disorder of the exocrine pancreas with no specific therapy." | ( Bao, J; Chen, C; Dai, J; He, Y; Hu, G; Husain, SZ; Jiang, M; Li, B; Li, L; Niu, M; Wen, L; Wu, Z; Zhang, X, 2021) |
| "PHPT masquerading as acute pancreatitis is rare and high index of suspicion is required to diagnose this condition especially in the presence of normocalcemia at presentation." | ( Arora, S; Kalra, S; Mittal, N; Shanthaiah, D; Singh, P; Sood, A; Verma, R, 2021) |
| "Acute pancreatitis is a disease associated with suffering and high lethality." | ( Fang, RH; Gao, W; Zhang, L; Zhang, Q; Zhou, J, 2021) |
| "Acute pancreatitis is a common reason for presentation to EDs." | ( Morton, A, 2022) |
| "Acute pancreatitis is an inflammatory disease accompanied by pancreatic inflammation characterized by acinar cell damage and leukocyte infiltration in the tissue." | ( Akyüz, C; Gökçeimam, M; Harman Kamalı, G; Karahan, SR; Özsoy, A; Tazeoğlu, D, 2021) |
| "Acute pancreatitis is one of the main reasons for hospitalization amongst gastrointestinal disorders worldwide." | ( Bhatia, M; Kumar, A, 2021) |
| "Acute pancreatitis is still a life-threatening disease without an evidenced therapeutic agent." | ( Hirokawa, F; Jin, D; Komeda, K; Kuramoto, T; Takai, S; Taniguchi, K; Uchiyama, K, 2021) |
| "Acute pancreatitis is a common disease, and the mortality rate can be high." | ( Bende, F; Dancu, GM; Danila, M; Popescu, A; Sirli, R; Sporea, I; Tarta, C, 2021) |
| "BACKGROUND Acute pancreatitis is the leading gastrointestinal cause of hospitalization in the United States." | ( Cammarano, CA; Sandhu, NS; Villaluz, JE, 2021) |
| "Acute pancreatitis is one of the most common complications of endoscopic retrograde cholangiopancreatography (ERCP)." | ( Aletaha, N; Alipour, A; Hamid, H; Ketabi Moghadam, P, 2022) |
| "Acute pancreatitis is a common and potentially serious condition." | ( Chayanupatkul, M; Klaikeaw, N; Siriviriyakul, P; Somanawat, K; Sriko, J; Werawatganon, D, 2022) |
| "Acute pancreatitis is characterized by necrosis of its parenchymal cells and influx and activation of inflammatory cells that further promote injury and necrosis." | ( Gottlieb, RA; Pandol, SJ, 2022) |
| "Acute pancreatitis is a severe inflammatory disease of the pancreas." | ( Ahn, YJ; Kim, H; Lim, JW, 2022) |
| "Acute pancreatitis is a serious gastrointestinal disease that is an important target for drug safety surveillance." | ( Ajao, A; Ball, R; Bann, MA; Carrell, DS; Felcher, AH; Floyd, JS; Hazlehurst, B; Nelson, JC; Nguyen, MD; Sapp, D, 2023) |
| "Acute pancreatitis is the sudden inflammation of the pancreas." | ( Fang, Q; Xiao, J; Zeng, W; Zhang, P; Zhou, Y, 2022) |
| "Acute pancreatitis is a common indication for hospital admission, increasing in incidence, including in children, pregnancy and the elderly." | ( Beyer, G; Cai, W; Grammatikopoulos, T; Halloran, C; Huang, W; Mukherjee, R; Sutton, R; Szatmary, P, 2022) |
| "Acute pancreatitis is characterized by rapid inflammation and autodigestion of the pancreas, which may become life-threatening." | ( Aguiar, T; Chakravorty, S; He, S; Ikner, TP; Taylor, BV; Thakur, NP, 2022) |
| "Key Points • Acute pancreatitis is a rare complication of immunoglobulin A vasculitis (IgAV)." | ( Du, L; Liu, C; Mu, J; Wang, X; Yang, Y, 2023) |
| "Acute pancreatitis is a serious threat to human health and gastrointestinal dysmotility is a common complication for acute pancreatitis patients, resulting in delayed feeding, oral feeding intolerance, paralytic ileus, and abdominal compartment syndrome." | ( Du, T; Sheng, Y; Sun, H; Zhu, H, 2023) |
| "Acute pancreatitis is a systemic inflammatory disorder characterized by the hyperactivation of digestion enzymes and the release of proinflammatory cytokines." | ( Acikel-Elmas, M; Arbak, S; Cilingir, S; Kolgazi, M, 2023) |
| "Acute pancreatitis is a clinical picture with a wide range of symptoms from mild inflammation to multiorgan failure and death." | ( Çırak, Z; Güney, BÇ; Kaplan, M; Sade, AG; Serindağ, Z; Tanoğlu, A; Taştan, YÖ; Yeniçeri, M, 2022) |
| "Acute pancreatitis is an inflammatory response in the pancreas, involving activation of pancreatic enzymes." | ( Hu, Q; Hu, X; Tao, R; Wu, H; Xu, J, 2023) |
| "Severe acute pancreatitis is a common disease in the intensive care unit with high mortality." | ( Cai, Z; Chen, Y; Li, Q; Ma, L; Zhou, J, 2023) |
| "Development of acute pancreatitis is associated with mitochondrial dysfunction and decreased cytosolic ATP level." | ( Manko, BO; Manko, VV; Ostapiv, RD; Zub, AM, 2023) |
| "Acute pancreatitis is a common and serious inflammatory condition currently lacking disease modifying therapy." | ( Brines, M; Chavan, SS; George, SJ; Hepler, TD; Hyde, D; Pavlov, VA; Rishi, A; Thompson, DA; Tracey, KJ; Tsaava, T, 2023) |
| Excerpt | Reference |
|---|
| "The development of acute pancreatitis in an 8-year-old boy being treated with valproic acid for simple absence spells is documented." | ( Batalden, PB; Cloyd, J; Van Dyne, BJ, 1979) |
| "Standard medical management of acute pancreatitis includes measures to relieve pain and maintain intravascular volume, nasogastric aspiration of gastric contents, and prompt recognition and treatment of complications." | ( Regan, PT, 1979) |
| "More active treatment of acute pancreatitis is suggested." | ( Ahonen, J; Brotherus, JV; Collan, R; Eklund, B; Kock, B; Kuhlbäck, B; Lindfors, O; Lindström, BL, 1977) |
| "The treatment of acute pancreatitis as currently practised in Austria was evaluated by means of a questionnaire mailed to all medical and surgical departments in Austrian hospitals." | ( Brunner, H; Grabner, G; Wurm, E, 1979) |
| "Sixty-two cases of acute pancreatitis, evaluated for severity according to uniform standards, were treated identically except that patients in one group received glucagon hydrochloride (group A) and those in the other oxyphenonium bromomethylate (group B)." | ( Gilsanz, V; Oteyza, CP; Rebollar, JL, 1978) |
| "Personal experience in the treatment of acute pancreatitis with glucagon is reported." | ( Gargiulo, A; Stagnitti, F, 1979) |
| "Fifty-eight patients with acute pancreatitis were randomly divided into antibiotic and non-antibiotic treatment groups." | ( Finch, WT; Sawyers, JL; Schenker, S, 1976) |
| "16 patients suffering from acute pancreatitis were treated by intramuscular or intravenous administration of glucagon, with control of the amylasemia and amylasuria values at the start of treatment, the 12th hour and the 36th hour." | ( Cirino, E; Platania, P; Polto, F; Vadalà, G, 1976) |
| "The effect of insulin treatment in acute pancreatitis was studied in a double-blind investigation." | ( Svensson, JO, 1975) |
| "An example of acute pancreatitis developing five weeks after initial treatment with 5-aminosalicylic acid (5-ASA) and methylprednisolone for severe Crohn's disease is reported in a 37 year old female patient." | ( Hüppe, D; May, B; Micklefield, GH; Schwegler, U; Tromm, A, 1992) |
| "We report five cases of patients with acute pancreatitis (AP) resistant to conventional treatment who improved dramatically with clonidine." | ( Cabrera, A; Jara, H; Jiménez, V; Lechin, A; Lechin, F; Lechin, M; Orozco, B; Rada, I; Valderrama, T; van der Dijs, B, 1992) |
| "An 80-year-old man had acute pancreatitis during the fourth week of antibiotic therapy for enterococcal endocarditis and 12 days after initiation of ketoprofen therapy for osteoarthritis of the hip." | ( Cobb, TK; Pierce, JR, 1992) |
| "To study the development of acute pancreatitis after intraductal trypsin instillation, at 4 hours, 1, 2, 4 and 6 days after this treatment and after instillation of physiologic saline viable acinar cells were isolated from rat pancreas." | ( Letko, G; Matthias, R; Richter, F, 1992) |
| "99 patients affected with acute pancreatitis of different genesis were treated in hospital (necrotizing n = 38, mild form n = 61) from May 1990 to November 1991." | ( Buchner, M; Kuklinski, B; Müller, T; Schweder, R, 1992) |
| "Postulating that the acute pancreatitis must be a "free radical disease", in a randomized clinical study the adjuvant therapy of the acute necrotizing pancreatitis (n = 8) with sodium selenite was carried out in a daily dose of 500 micrograms." | ( Buchner, M; Kuklinski, B; Nagel, R; Schweder, R, 1991) |
| "In both models of acute pancreatitis, the levels of serum amylase activity were reduced significantly by the treatment of CV-3611." | ( Kyogoku, T; Manabe, T; Nonaka, A; Tamura, K; Tobe, T, 1990) |
| "Therefore CCK administration in slight acute pancreatitis could be used as a therapy since it favours the secretion of pancreatic enzymes at percentual levels similar to those of the controls." | ( Calvo, JJ; De Dios, I; López, MA; Manso, MA; San Román, JI, 1990) |
| "Existing models of acute pancreatitis have limitations to studying novel therapy." | ( Compton, CC; Knoefel, WT; Lewandrowski, K; Mandavilli, U; Rattner, DW; Schmidt, J; Warshaw, AL, 1992) |
| "The authors treated destructive forms of acute pancreatitis for the first time by means of specific plasma sorption of proteinases with the use of a proteinase plasma sorbent which is an acid-stable proteinase inhibitor immobilized on sepharose (ASI-Sepharose)." | ( Belova, LA; Brekhov, EI; Denisov, AIu; Kalinnikov, VV; Konovalov, GA; Malinovskiĭ, NN; Ogloblina, OG; Privalov, GV; Starostenko, AV, 1991) |
| "Early reports of acute pancreatitis after tetracycline administration were associated with liver dysfunction attributed to the drug's ability to induce fatty degeneration of this organ." | ( Kline, JJ; Mengedoht, DE; Nicolau, DP, 1991) |
| "We report the development of acute pancreatitis and permanent diabetes mellitus in an AIDS patient treated with intravenous pentamidine for Pneumocystis pneumonia." | ( Hogan, P; Wetzig, N; Whitby, M; Wood, G, 1991) |
| "On day 14 after treatment typical acute edematous pancreatitis developed." | ( Gabriélian, NA; Kanaian, AS; Karalova, EM; Magakian, IuA, 1990) |
| "We report on a patient with acute pancreatitis whose pain was resistant to simultaneous administration of morphine, procaine and Buscopan." | ( Borgeat, A; Chanson, C; Nicolet, A; Schwander, D, 1990) |
| "Comparing the two groups of acute pancreatitis patients after 6 days of treatment with gabexate mesilate, we observed a statistically significantly lower alpha-amylase activity in the serum of treated patients compared with the placebo group." | ( Freise, J; Magerstedt, P; Schmid, K; Schmidt, FW, 1985) |
| "The results indicate that treatment of acute pancreatitis in humans with alpha 2-macroglobulin might be possible, without any danger arising from the protease-alpha 2-macroglobulin complexes formed." | ( Lasson, A; Ohlsson, K; Sjölund, B, 1987) |
| "A patient with Crohn's disease developed acute pancreatitis 4 h after retaking one 50 mg dose of orally administered 6-mercaptopurine (6-MP)." | ( Cappell, MS; Das, KM, 1989) |
| "In the experiment on 200 rats with acute pancreatitis, it was revealed that in administration of dalargin at a dose of 10 mg/kg of the mass, the activity of xanthinoxidase and lipid peroxidation in the pancreas was suppressed, at the same time, the activity of trypsin, amylase and transamidinase in the blood serum decreased." | ( Grigorevskiĭ, VP; Karelin, AA; Korotkina, RN; Pomelov, VS; Shloznikov, BM, 1989) |
| "SST has no effect on the outcome of acute pancreatitis, and experience with SST in treating intestinal fistulas is very limited." | ( Gyr, K; Kayasseh, L; Stalder, GA, 1985) |
| "Severe forms of acute pancreatitis were treated in 53 patients (25 with a destructive form, 28 with an edematous form) with using permanent infusions of a novocaine cocktail into the retroperitoneal space." | ( Eĭdel'man, LA; Khadun'kin, VV; Kochkarev, FG; Margulis, MS; Savchenko, VB, 1987) |
| "For medical treatment of acute pancreatitis, only very few effective measures can be recommended." | ( Neumayr, A, 1980) |
| "Sixty-six patients with acute pancreatitis admitted to the surgical service of the Vancouver General Hospital were randomized into two groups of 33, receiving either glucagon or placebo in addition to their conventional therapy." | ( Cassim, MM; Debas, HT; Hancock, RJ; Smythe, HA; Soon-Shiong, P, 1980) |
| "Corticosteroid treatment of acute pancreatitis has recently been advocated by clinicians." | ( Guillan, RA; Lee, SH; Monto, GL; Watanabe, I, 1983) |
| "Azathioprine-associated acute pancreatitis is well recognized mostly during treatment of Crohn's disease and after renal transplantation." | ( Grandjean, E; Guillaume, P; Malè, PJ, 1984) |
| "This paper reports the association of acute pancreatitis coincident with cytosine arabinoside (Ara-c) therapy in a single patient on at least two occasions." | ( Altman, AJ; Dinndorf, P; Quinn, JJ, 1982) |
| "Trials of treatment of acute pancreatitis with 5-fluorouracil were undertaken also in two cases with good result." | ( Popiela, T; Turczynowski, W; Zajac, A, 1980) |
| "Twenty patients with documented acute pancreatitis randomly received treatment with nasogastric suction, cimetidine alone, or the combination of cimetidine and glucagon." | ( DiMagno, EP; Go, VL; Malagelada, JR; Regan, PT; Wolf, AM, 1981) |
| "Among 1613 patients treated for acute pancreatitis in 1993, drug induced acute pancreatitis was diagnosed in 22 patients (incidence 1." | ( Dröge, M; Gottesleben, F; Lankisch, PG, 1995) |
| "Early and appropriate treatment of acute pancreatitis (AP) depends on early causal diagnosis." | ( Boutroux, D; Bretagne, JF; Gosselin, M; Heresbach, D; Lebert, P; Nicol, M; Raoul, JL; Siproudhis, L, 1994) |
| "In rats with acute pancreatitis treated with SNP, oxidative stress, expressed by malondialdehyde increase and sulphhydryl group depletion, was much more pronounced than in the other groups." | ( Dabrowski, A; Gabryelewicz, A, 1994) |
| "A 25-year old man suffered from acute pancreatitis and cholestatic acute hepatitis simultaneously after 4 weeks of an antibiotic treatment withdrawal (amoxicillin plus clavulanic acid) which was given for pharyngitis." | ( Buenestado, J; Galindo, C; Piñol, MC; Reñé, JM, 1995) |
| "An improvement in the prognosis of acute pancreatitis can be achieved if antioxidative selenium therapy with sodium selenite is introduced in time." | ( Kuklinski, B; Schweder, R; Zimmermann, T, 1995) |
| "The authors conclude that acute pancreatitis is a relatively infrequent complication of antimonial treatment for VL in patients with HIV infection and believe that a maximum dose of 850 mg/day should not be surpassed." | ( Cortés, E; Cucurull, E; de Otero, J; Ocaña, I; Pahissa, A; Ribera, E, 1995) |
| "In rats with acute pancreatitis treated with these proteinase inhibitors, oxidative stress expressed by malondialdehyde elevation and sulfhydryl groups depletion, was markedly diminished." | ( Dabrowski, A; Gabryelewicz, A, 1994) |
| "From 20 patients with acute pancreatitis the activities of the antioxidative enzymes glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) were estimated in the blood serum immediately before and during therapy with sodium selenite." | ( Karnstedt, U; Zelck, U, 1993) |
| "We reported a case of acute pancreatitis occurring during administration of valproic acid for epilepsy." | ( Ito, S; Kobayashi, K; Kuniya, T; Mimasu, S; Momota, T, 1993) |
| "Third, acute pancreatitis could be observed in rats with elevated serum calcium levels at low doses of cerulein (5 micrograms/kg/hr, subcutaneously), but could not be observed in rats with normal serum calcium levels treated with low doses of cerulein." | ( Han, Q; Miller, JE; Olson, MS; Shen, F; Zhou, W, 1996) |
| "Taken together, in further studies of acute pancreatitis therapy, BPC could be an interesting and useful agent with an additional positive impact on concomitant gastroduodenal pathology." | ( Artuković, B; Bratulić, M; Buljat, G; Gjurasin, M; Grabarević, Z; Hanzevacki, M; Jagić, V; Jelovac, N; Jurina, L; Konjevoda, P; Ljubanović, D; Mise, S; Petek, M; Rotkvić, I; Rucman, R; Seiwerth, S; Separović, J; Sikirić, P; Turković, B; Zoricić, I, 1996) |
| "In rats with acute pancreatitis induced by four subcutaneous injections of 20 mu g/kg body wt cerulein at hourly intervals over 3 h, MCI-727 administered orally at a dose of 100 mg/kg body wt 30 min before the first cerulein injection significantly reduced the increases in serum amylase and lipase activity and pancreatic wet weight and induced improvements in the results of histologic examination." | ( Akiyama, T; Nakano, S; Otsuki, M; Shirohara, H; Tachibana, I; Watanabe, N, 1996) |
| "After the cessation of repetition of acute pancreatitis the rats were treated with successive feeding with 0." | ( Kimura, T; Nakano, I; Nawata, H; Song, W; Yamaguchi, H, 1996) |
| "The indications of acute pancreatitis, as well as the mortality, were improved by Zn treatment before the onset of acute pancreatitis." | ( Iguchi, H; Imamura, M; Imamura, T; Ohshio, G; Okada, N; Tanaka, T; Wang, ZH, 1996) |
| "To clarify the role of NO in acute pancreatitis, we investigated the serum concentrations of NO chi (NO2- plus NO3-) and tumor necrosis factor-alpha (TNF-alpha) and the grade of pancreatitis in cerulein-induced pancreatitis in mice pretreated with lipopolysaccharide (LPS) or not." | ( Abe, R; Abe, T; Kikuchi, Y; Koizumi, M; Satoh, A; Shimosegawa, T; Toyota, T, 1996) |
| "We describe two cases of acute pancreatitis that occurred after long term mesalamine therapy for ulcerative colitis." | ( Fernández, J; Feu, F; Navarro, S; Panés, J; Sala, M; Terés, J, 1997) |
| "Interestingly, during acute pancreatitis, CD-1 mice pretreated with L-buthionine-[S,R]-sulfoximine (BSO), which dramatically depleted pancreatic GSH, also had more severe pancreatitis, based on the same three criteria listed above, relative to untreated controls." | ( Andrews, GK; De Lisle, RC; Fu, K; Sarras, MP; Tomita, T, 1998) |
| "We treated five patients with severe acute pancreatitis by continuous arterial infusion (CAI) of protease inhibitor, nafamostat mesilate." | ( Fukui, K; Hara, A; Ichikawa, M; Ito, T; Matsukawa, H; Okuda, S; Sato, K; Seki, H; Shiraga, N; Takizawa, K; Yamataka, K; Yoshioka, M, 1998) |
| "In most treatment studies on acute pancreatitis, pancreatologists base their diagnosis on amylase/lipase levels more than three times above the upper limit of normal (>3n) and thus exclude patients with smaller enzyme level increases." | ( Burchard-Reckert, S; Lankisch, PG; Lehnick, D, 1999) |
| "This is the first report of acute pancreatitis developed by oral 5-ASA therapy for the treatment of ulcerative colitis in the literature of Japan." | ( Adachi, E; Chiba, T; Kawanami, C; Matsushima, Y; Nakamura, T; Nakase, H; Okazaki, K; Seno, H; Uchida, K, 1999) |
| "Severe acute pancreatitis or colitis was induced in rats randomized for therapy with or without glutamine (0." | ( Buhr, HJ; Eibl, G; Foitzik, T; Hotz, HG; Kroesen, AJ; Kruschewski, M, 1999) |
| "During acute pancreatitis induction, rats were treated with L-arginine (a substrate for NO synthesis), glyceryl trinitrate (NTG, NO donor), glycine, N(G)-nitro-L-arginine (L-NNA, NO synthase inhibitor), L-arginine + L-NNA, or saline." | ( Dzieciol, J; Gabryelewicz, A; Jurkowska, G; Rydzewska, G, 1999) |
| "Pancreas destruction after acute pancreatitis was evidenced by similar decreases of all parameters in untreated acute pancreatitis rats or those treated with L-NNA or glycine when compared to control healthy animals." | ( Dzieciol, J; Gabryelewicz, A; Jurkowska, G; Rydzewska, G, 1999) |
| "During acute pancreatitis induction, the rats were treated with L-arginine (the substrate for NO synthesis), NG-nitro-L-arginine (L-NNA, NO synthase inhibitor), L-arginine + L-NNA or saline." | ( Andrzejewska, A; Jurkowska, G, 1999) |
| "Caerulein administration caused acute edematous pancreatitis with biochemical and histological manifestation of pancreatic damage, followed by spontaneous regeneration." | ( Ceranowicz, P; Dembiński, A; Konturek, PC; Konturek, SJ; Stachura, J; Tomaszewska, R; Warzecha, Z, 2000) |
| "Two patients experienced episodes of acute pancreatitis shortly after starting treatment with interferon alfa-2b (IFN-alpha) for a chronic hepatitis C infection." | ( Bekkering, FC; Belaiche, J; Brouwer, JT; Delwaide, J; Eland, IA; Houbiers, G; Rasch, MC; Stricker, BH; Sturkenboom, MJ, 2000) |
| "Sixteen patients had mild acute pancreatitis (AP) and 35 severe AP (Atlanta classification); 18 patients developed systemic complications requiring treatment." | ( Beger, HG; Gansauge, F; Mayer, J; Rau, B, 2000) |
| "Whole gut washout for acute pancreatitis appears effective to ameliorate the prognostic factors in blood and this modality may be a promising treatment method in acute pancreatitis." | ( Aksoy, F; Ozer, S; Vatansev, C; Yol, S, 2000) |
| "Rapid determination of the etiology of acute pancreatitis (AP) enables institution of appropriate treatment." | ( Andersén, JM; Finne, P; Hedström, J; Kemppainen, E; Puolakkainen, P; Stenman, UH, 2001) |
| "Treatment of patients with acute pancreatitis has greatly improved due to a better understanding of the pathophysiology of the disease." | ( Frossard, JL; Pastor, CM, 2001) |
| "The mortality of acute pancreatitis in a kidney transplant patient is, in spite of treatment with the most up-to-date methods, is much higher (53-60%) than that for a non-transplant patient." | ( Asztalos, L; Balzs, G; Berczi, C; Fedor, R; Kincses, Z; Locsey, L; Szabo, L, 2001) |
| "Between 1985 and 1994, 883 cases of acute pancreatitis were treated in Malmö, Sweden (population 233,000)." | ( Appelros, S; Borgström, A; Lindgren, S, 2001) |
| "In cerulein-induced acute edematous pancreatitis, treatment with taurine significantly decreased hyperamylasemia, tissue MPO, pancreatic edema, and the extent of pancreatic and pulmonary injury." | ( Ahn, BO; Hyun, JH; Kim, CD; Kim, KH; Kim, WB; Kim, YS; Lee, G; Lee, HS; Oh, TY; Son, MW, 2001) |
| "Fifteen consecutive patients with acute pancreatitis of suspected biliary origin were recruited from a population of 309 patients with acute pancreatitis (5%) treated during the last 4 years." | ( Kaczor, R; Kohut, M; Marek, T; Nowak, A; Nowakowska-Duława, E, 2001) |
| "Elucidation of the key mediators in acute pancreatitis coupled with the discovery of specific inhibitors may make it possible to develop clinically effective anti-inflammatory therapy." | ( Bhatia, M; Neoptolemos, JP; Slavin, J, 2001) |
| "Caerulein administration induced acute edematous pancreatitis manifested by 41% decrease in DNA synthesis, 53% inhibition of pancreatic blood flow, a significant increase in plasma amylase and lipase activity, plasma interleukin-1beta and interleukin-6 concentration, as well as, the development of the histological signs of pancreatic damage (edema, leukocyte infiltration, and vacuolization)." | ( Ceranowicz, P; Dembiński, A; Konturek, PC; Konturek, SJ; Nakamura, T; Schuppan, D; Stachura, J; Tomaszewska, R; Warzecha, Z, 2001) |
| "Recurrent acute pancreatitis associated with metronidazole developed in a 49-year-old woman who was taking the drug as treatment for vaginal trichomoniasis." | ( Feola, DJ; Thornton, AC, 2002) |
| "After 10 days, acute pancreatitis was induced with four doses of 20 microg/kg body weight of cerulein administered s." | ( Batur, Y; Kumanlioglu, K; Oruç, N; Ozütemiz, AO; Yönetçi, N; Yüce, G, 2002) |
| "During acute pancreatitis, heparin administration might mobilize xanthine oxidase attached to endothelial cells, originating a free radical-generating system in the circulation that would trigger an inflammatory response in the lung." | ( Aparisi, L; Bulbena, O; Closa, D; Gelpí, E; Gironella, M; Granell, S; Mauri, M; Panés, J; Sabater, L, 2003) |
| "The mechanism of emodin in treating acute pancreatitis might be by way of enhancing cytokine TGF beta 1 gene expression, regulating cell growth and differentiation, stimulating the formation of extracellular matrix components, increasing DNA synthesis and protein content, and to take part in pancreatic repairing and remodeling." | ( Gong, ZH; Lou, KX; Yuan, YZ, 2001) |
| "A second group (acute pancreatitis treated control [n = 5]) was treated with a similar dose of an isotypic control for VCAM-1 (nonbinding Ab) at the same time points." | ( Callicutt, CS; Fukatsu, K; Gaber, AO; Gaber, L; Kotb, M; Lundberg, AH; Sabek, O; Wilcox, H, 2003) |
| "In treatment of severe acute pancreatitis of paramount importance are the terms of the beginning of antisecretory therapy, the optimum term being the first day of the disease." | ( Bagnenko, SF; Gol'tsov, VR; Nazarov, VE; Rukhliada, NV; Tolstoĭ, AD, 2002) |
| "Severe acute pancreatitis was induced in rats by the intraductal administration of taurodeoxycholate." | ( Andersson, R; Börjesson, A; Haraldsen, P; Lasson, A; Olanders, K; Sun, ZW, 2003) |
| "The incidence rate for acute pancreatitis among all users of azathioprine was one per 659 treatment year." | ( Floyd, A; Nielsen, GL; Pedersen, L; Sorensen, HT; Thorlacius-Ussing, O, 2003) |
| "Identical acute pancreatitis was induced in the control animals, however no other substances were administered." | ( Celiński, K; Cichoz-Lach, H; Kasztelan-Szczerbińska, B; Szczerbiński, M; Słomka, M, 2002) |
| "In Wistar rats, severe acute pancreatitis was induced by administration of glucodeoxycholic acid i." | ( Bloechle, C; Izbicki, JR; Kleinhans, H; Knoefel, WT; Mann, O; Schneider, C; Standl, T; Strate, T; Yekebas, E, 2003) |
| "Although the pathogenesis of acute pancreatitis is poorly understood, there are many studies that suggest the role for oxygen free radicals (OFRs) in the development of pancreatitis and its complications and show beneficial effects of scavenger treatment." | ( Deveci, S; Gorgulu, S; Kaymakcioglu, N; Ozcelik, H; Serdar, M; Simsek, A; Tufan, T; Yagci, G; Zeybek, N, 2003) |
| "Inosine reduced the severity of acute pancreatitis, suggesting a possible application of this compound in the treatment of acute pancreatitis." | ( Kimura, K; Masamune, A; Sakai, Y; Satoh, A; Shimosegawa, T; Yamagiwa, T, 2004) |
| "Approximately 2% of cases of acute pancreatitis may be caused by drugs, but it is not a known complication of metformin therapy." | ( Mallick, S, 2004) |
| "The model of acute pancreatitis was established by subcutaneous injection of caerulein, and TCMP-1 treated groups were given TCMP-1 by catheterization from mouth to stomach (20 ml/kg) immediately after first time subcutaneous injection of caerulein." | ( Chen, YQ; Gao, HK; Han, FH; He, T; Wang, C; Zhou, ZG, 2004) |
| "Rats with cerulein induced acute edematous pancreatitis (CR), pancreatitis induced by cerulein and water immersion stress (CR + WIS) and closed duodenal loop pancreatitis (CDL) treated by tirilazad mesylate were sacrificed in 9 th hour of the experiment." | ( Chmiel, B; Cierpka, L; Grabowska-Bochenek, R; Pajak, J, 2003) |
| "Drug-induced acute pancreatitis should be in the differential diagnosis of acute abdomen occurring soon after initiation of tuberculosis treatment and chemoprophylaxis." | ( Chow, KM; Leung, CB; Li, PK; Szeto, CC, 2004) |
| "We report a case of recurrent acute pancreatitis in a 46-year-old female associated with oral metronidazole therapy and review the literature with regards to metronidazole-induced pancreatitis." | ( Casey, KJ; Nigwekar, SU, 2004) |
| "We present 738 acute pancreatitis patients, treated from 1991 to 2001 in our clinic." | ( Evtimov, R; Gachev, H; Iarumov, N; Ognianov, S; Stefanov, B; Vasilev, H, 2003) |
| "Protease inhibitors are used to treat acute pancreatitis, but their effectiveness remains unclear." | ( Fukui, T; Noguchi, Y; Seta, T; Shikata, S; Shimada, T, 2004) |
| "In a model of acute pancreatitis induced by caerulein hyperstimulation, prophylactic as well as therapeutic treatment with bindarit significantly reduced MCP-1 levels in the pancreas." | ( Bhatia, M; Chevali, L; Guglielmotti, A; Ramnath, RD, 2005) |
| "In Wistar rats, severe acute pancreatitis was induced by administration of glyco-deoxycholic-acid intraductally and cerulein intravenously." | ( Bloechle, C; Freitag, M; Izbicki, JR; Kleinhans, H; Mann, O; Rusani, S; Schneider, C; Standl, T; Strate, T; Yekebas, E, 2005) |
| "Severe acute pancreatitis was induced by the intraductal administration of 5% sodium taurodeoxycholate and pancreatitis-associated gut barrier dysfunction was characterized by increased exudation of radiolabelled albumin into the interstitium and alterations in bidirectional (over both the endothelial and epithelial barrier components) permeability of the intestine at the early stage of bile salt-induced acute pancreatitis." | ( Andersson, E; Andersson, R; Börjesson, A; Leveau, P; Sun, Z; Wang, X, 2005) |
| "We present a rare side effect, acute pancreatitis, occurring in a patient who was treated with the proton pump inhibitor omeprazole." | ( Iskandar, SB; Roy, TM; Scruggs, J; Youssef, SS, 2005) |
| "A 77-year-old man suffered from acute pancreatitis during the treatment of relapsed acute promyelocytic leukemia with As2O3." | ( Akioka, T; Hanafusa, T; Hara, S; Oka, T; Tsuji, M; Yamano, T; Yokote, T, 2006) |
| "The standard treatment for acute pancreatitis (AP) is still based on supportive care." | ( Coelho, AM; da Cunha, JE; de Almeida, JL; Jukemura, J; Machado, MC; Patzina, RA, 2006) |
| "The extent of acute pancreatitis was reduced in the therapy group as indicated by serum lipase/amylase values and histological tissue damage (P < 0." | ( Fiedler, M; Hauss, J; Lauer, H; Ludwig, S; Serr, F; Tannapfel, A; Uhlmann, D; Witzigmann, H, 2007) |
| "In cerulein-induced acute pancreatitis, treatment with BX471 significantly protected mice against lung injury associated with cerulein-induced pancreatitis by attenuating myeloperoxidase activity, an indicator of neutrophil recruitment, and lung morphological changes in histological sections." | ( Bhatia, M; He, M; Horuk, R, 2007) |
| "The mortality associated with acute pancreatitis (AP) is largely attributable to abnormalities that occur in distant organs and supportive care remains the only treatment for patients with these complications." | ( Berenguer-Pina, JJ; Hernández-Espinosa, D; Mota, R; Parrilla, P; Sánchez-Bueno, F; Yélamos, J, 2007) |
| "Dyspeptic symptoms are associated with acute pancreatitis, but some of them may be related to acute gastrointestinal mucosal lesions (AGML) and need acid-suppressive therapy." | ( Chen, HH; Chen, TA; Chen, WC; Hsu, PI; Lai, KH; Lin, CK; Lo, GH; Tsai, WL; Wong, HY; Yu, HC, 2007) |
| "Sixty-five percent of patients with acute pancreatitis complicate with AGML and may benefit by acid-suppressive therapy." | ( Chen, HH; Chen, TA; Chen, WC; Hsu, PI; Lai, KH; Lin, CK; Lo, GH; Tsai, WL; Wong, HY; Yu, HC, 2007) |
| "Ninety rats were prepared as severe acute pancreatitis models and were randomly divided into a control group and the dexamethasone treatment group (45 rats in each group)." | ( Cai, J; Cai, W; Cheng, QH; Shen, HP; Wang, JM; Wang, Y; Zhang, L; Zhang, XP, 2007) |
| "Sixty-eight cases of acute pancreatitis were randomly divided into a treatment group and a control group." | ( Wang, XY, 2007) |
| "Identifying acute pancreatitis as a possible consequence of a certain medication in inflammatory bowel disease patients may be particularly important to determine further treatment of their disease." | ( Ekonomou, IA; Giannoulis, EK; Giannoulis, KE; Savopoulos, CG; Tsesmeli, NE; Vretou, EE, 2007) |
| "Before induction of acute pancreatitis, rats were treated with hydrocortisone (n = 20) or 0." | ( Sun, W; Toki, A; Wang, ZQ; Watanabe, Y, 2007) |
| "Compared to untreated animals with acute pancreatitis, rats pretreated with hydrocortisone had significantly reduced histological lung injury and output of ascitic fluid." | ( Sun, W; Toki, A; Wang, ZQ; Watanabe, Y, 2007) |
| "Severe acute pancreatitis was induced by 20% L-arginine abdominal cavity injection in Institute of Cancer Research mice, and the treatment group received 2 abdominal cavity injections of A box 12 and 24 hours after the modeling injection." | ( Cao, Y; Feng, Q; Jin, X; Li, F; Sun, J; Wang, Y; Yuan, H; Zhang, C, 2009) |
| "Of patients with acute pancreatitis (AP), 20% develop severe attacks that need early and intensive therapy." | ( Gurda-Duda, A; Kulig, J; Kuśnierz-Cabala, B; Naskalski, JW; Nowak, W, 2008) |
| "Only severe acute pancreatitis requires treatment, according to the principles of intensive care medicine in an intensive care or intermediate care unit." | ( Hebel, K; Lankisch, PG; Lowenfels, AB; Maisonneuve, P; Weber-Dany, B, 2009) |
| "Moreover, the increased incidence of acute pancreatitis during growth hormone therapy is possibly due to increased enzyme production (e." | ( Acquafredda, A; Cavallo, L; Delvecchio, M; Faienza, MF; Francavilla, R; Indrio, F, 2009) |
| "A novel case of acute pancreatitis in a patient treated with percutaneous ethanol injection (PEI) ablation for hepatocellular carcinoma is described." | ( Burton, KR; O'Dwyer, H; Scudamore, C, 2009) |
| "Of the cases of acute pancreatitis, 1-7% are caused by severe hypertriglyceridemia and can be treated with plasma exchange (PE)." | ( Buturović-Ponikvar, J; Gubensek, J; Knap, B; Kovac, J; Marn-Pernat, A; Ponikvar, R; Premru, V, 2009) |
| "In animals with induction of acute pancreatitis, morphological examination showed that administration of obestatin decreased pancreatic leukocyte infiltration and vacuolization of acinar cells." | ( Ceranowicz, P; Cieszkowski, J; Dembinski, A; Dembinski, M; Kato, I; Kusnierz-Cabala, B; Kuwahara, A; Sendur, R; Tomaszewska, R; Warzecha, Z, 2009) |
| "Current treatment options for acute pancreatitis are supportive and symptomatic." | ( Khanduja, KL; Malhotra, S; Pandhi, P; Sidhu, S; Vaiphei, K, 2010) |
| "Pathogenesis of severe acute pancreatitis is still unclear, which leads to a lack of proper treatment in severe acute pancreatitis therapeutic strategy." | ( Chen, TK; Liu, NX; Wu, L; Zhang, QY; Zhang, ZW; Zhou, MT; Zhu, YF, 2010) |
| "Severe acute pancreatitis is a life threatening disease with a high rate of mortality, and its treatments are still controversial." | ( Dong, X; Gao, SL; Jiang, RY; Peng, JP; Wang, J; Wu, YL; Xie, QP; Zhan, YC, 2010) |
| "Although infrequent, acute pancreatitis, and less often chronic pancreatitis, may occur as a result of the disease itself or secondary to the medications used in the treatment." | ( Das, K; Pitchumoni, CS; Rubin, A, 2010) |
| "We present a case of acute pancreatitis in a 14-year-old girl which fulfilled the diagnostic criteria of autoimmune pancreatitis (AIP) and responded to corticosteroid therapy." | ( Imai, T; Nozaki, F; Takase, M, 2010) |
| "To analyze susceptibility to acute pancreatitis, five mouse strains including Japanese Fancy Mouse 1 (JF1), C57BL/6J, BALB/c, CBA/J, and C3H/HeJ were treated with either a cholecystokinin analog, cerulein, or a choline-deficient, ethionine-supplemented (CDE) diet." | ( Araki, K; Baba, H; Hirota, M; Nakagata, N; Ohmuraya, M; Ozaki, N; Suyama, K; Wang, J; Yamamura, K, 2010) |
| "Two weeks later, he developed painless acute pancreatitis associated with sorafenib treatment." | ( Fujimoto, T; Itatani, H; Kamoto, A; Kanemitu, T; Kobayashi, Y; Mori, N; Satoh, M; Sekii, K; Yoshioka, T, 2011) |
| "Recent case reports of acute pancreatitis in patients with type 2 diabetes (T2DM) treated with incretin-based therapies have triggered interest regarding the possibility of a mechanism-based association between pancreatitis and glucagon-like peptide-1 mimetics or dipeptidyl peptidase-4 (DPP-4) inhibitors." | ( Clay, RJ; Engel, SS; Goldstein, BJ; Golm, GT; Kaufman, KD; Machotka, SV; Williams-Herman, DE, 2010) |
| "Forty-four patients with severe acute pancreatitis were enrolled into a prospective study and treated according to the standard management protocol." | ( Barauskas, G; Dambrauskas, Z; Gulbinas, A; Maleckas, A; Parseliūnas, A; Pundzius, J, 2010) |
| "Severe acute pancreatitis (SAP) remains a challenging disease to manage, with high mortality, limited understanding of pathogenesis and lack of specific therapy." | ( Jiang, W; Lin, X; Luo, S; Qiu, P; Wang, R; Yan, G, 2010) |
| "We report a case of recurrent severe acute pancreatitis in a 44-year-old female induced by tamoxifen therapy and review the literature with regards to tamoxifen-associated pancreatitis." | ( Ben Salem, C; Fathallah, N; Harbi, H; Ltaief, R; Sakhri, J, 2010) |
| "The severity of acute pancreatitis was assessed between 0 h and 10 days after cessation of cerulein administration." | ( Ceranowicz, P; Cieszkowski, J; Dembinski, A; Kato, I; Kusnierz-Cabala, B; Kuwahara, A; Tomaszewska, R; Warzecha, Z, 2010) |
| "In human acute pancreatitis (AP) the local anaesthetic procainhydrochloride (procain-HCl) is given intravenously for pain treatment." | ( Kahl, S; Malfertheiner, P; Mayer, J; Nevalainen, TJ; Peuravuori, H; Pross, M; Schuette, K; Schulz, HU, 2010) |
| "In the acute pancreatitis model, among five time points at which plasmas were sampled, miR-216a concentrations were significantly elevated 24 h after arginine administration and remained significantly increased until 48 h after operation (compared with 0 h time point, P < 0." | ( Deng, SX; Du, YQ; Gong, YF; Gu, JJ; Kong, XY; Li, L; Li, ZS; Liu, JQ; Man, XH; Wang, GK; Xiao, LN; Zheng, YZ; Zhu, JQ, 2010) |
| "Cerulein-induced acute pancreatitis was markedly attenuated by the administration of VK3." | ( Azuma, T; Chinzei, R; Fujita, T; Itoh, T; Kutsumi, H; Masuda, A; Mizuno, S; Moritoh, S; Nishida, M; Nishiumi, S; Onoyama, M; Sanuki, T; Yoshida, M, 2011) |
| "Cerulein was administered to induce acute pancreatitis in rats." | ( Eser, M; Kaptanoglu, L; Kucuk, HF; Kurt, N; Tasdogan, B; Uzun, H, 2010) |
| "Reports of acute pancreatitis associated with exenatide treatment prompted this study to estimate the association between acute pancreatitis and exenatide use relative to other antihyperglycaemic drugs." | ( Bloomgren, GL; Braun, DK; Clifford, CR; Dore, DD; Hoffman, C; Noel, RA; Quinn, SG; Seeger, JD; Wenten, M, 2011) |
| "Drug-induced acute pancreatitis should be considered in the differential diagnosis of acute abdomen occurring soon after the initiation of antitubercular treatment." | ( Pandey, AS; Surana, A, 2011) |
| "NDGA was administered after 9 h of acute pancreatitis induction." | ( Gupta, C; Karpe, PA; Mahajan, UM; Tikoo, K; Wagh, PR, 2011) |
| "To assess the incidence of acute pancreatitis in human immunodeficiency virus-positive patients with triglyceride (TG) greater than 500 mg/dL after highly active antiretroviral therapy." | ( Chang, SC; Chang, SY; Chen, MY; Hsieh, SM; Hung, CC; Liu, WC; Lu, CL; Sheng, WH; Sun, HY; Tseng, YT; Wu, CH; Wu, H; Yang, CJ, 2012) |
| "The risk of acute pancreatitis was low among human immunodeficiency virus-positive patients who developed hypertriglyceridemia after receiving highly active antiretroviral therapy." | ( Chang, SC; Chang, SY; Chen, MY; Hsieh, SM; Hung, CC; Liu, WC; Lu, CL; Sheng, WH; Sun, HY; Tseng, YT; Wu, CH; Wu, H; Yang, CJ, 2012) |
| "After induction of acute pancreatitis, in group 1 volume administration was guided by central venous pressure (CVP >12 mmHg) and mean arterial pressure (MAP)." | ( Bachmann, KA; Friedheim, TJ; Goepfert, MS; Goetz, AE; Hinsch, A; Izbicki, JR; Mann, O; Reuter, DA; Stork, JH; Trepte, CJ, 2013) |
| "Children with acute pancreatitis have been treated by fasting and parenteral nutritional support, and to date, the efficacy of drugs for acute pancreatitis in children is unclear." | ( Kim, SC; Yang, HR, 2013) |
| "The following report describes a case of acute pancreatitis secondary to hypercalcemia in a 6-year-old boy with pseudohypoparathyroidism treated with calcium and vitamin D." | ( Calvo, L; Corrias, A; de Sanctis, L; Feyles, F; Mussa, A; Peiretti, V; Santanera, A; Tessaris, D, 2014) |
| "Severe acute pancreatitis (SAP) and mild acute pancreatitis (MAP) were induced and pre-treated with pioglitazone, which is a ligand of PPAR-γ." | ( Chen, C; Lou, XL; Xu, P; Yang, ZW, 2013) |
| "Numerous cases of acute pancreatitis have been reported after treatment with nonselective tyrosine kinase inhibitors such as sorafenib and sunitinib." | ( Khenifer, S; Pasquet, F; Pavic, M; Péron, J; Potier, V; Rassat, R; Vitry, T, 2014) |
| "Our goal is to present a case of acute pancreatitis secondary to hypertriglyceridemia, differential diagnosis and treatment approach." | ( Aslan, T; Aykas, F; Erden, A; Karagoz, H; Karahan, S; Karaman, A; Mutlu, H; Uslu, E, 2013) |
| "We aimed to compare the occurrence of acute pancreatitis in a population of patients with type 2 diabetes who received incretins compared with those who received other antidiabetic treatment." | ( Costa, G; Giorda, CB; Gnavi, R; Marafetti, L; Nada, E; Picariello, R; Tartaglino, B, 2014) |
| "Severe acute pancreatitis is a life-threatening disease with a high mortality; so far, no causal treatment is known." | ( Bachmann, K; Dupree, A; Freitag, M; Izbicki, JR; Koops, S; Lohalm, H; Mann, O; Strate, T; Tomkötter, L, 2014) |
| "Severe acute pancreatitis was induced by intraductal injection of glycodeoxycholic acid in combination with intravenous administration of cerulein." | ( Bachmann, K; Dupree, A; Freitag, M; Izbicki, JR; Koops, S; Lohalm, H; Mann, O; Strate, T; Tomkötter, L, 2014) |
| "Complicating acute pancreatitis was gradually but completely resolved after cessation of ciprofloxacin administration." | ( Cheung, DY; Cho, HJ; Cho, SH; Kim, JI; Kim, JK; Kim, SS; Lee, HJ; Sung, HY, 2014) |
| "Early detection of infection in acute pancreatitis (AP) affects the choice of treatment and clinical outcome." | ( Bhattacharya, A; Kalra, N; Khandelwal, N; Kochhar, R; Mittal, BR; Ray, P; Sharma, S, 2014) |
| "A 47-year-old man developed acute pancreatitis during combination treatment with telaprevir/peginterferon/ribavirin for chronic hepatitis C." | ( Aikata, H; Chayama, K; Fujino, H; Fukuhara, T; Hiramatsu, A; Imamura, M; Kan, H; Kawaoka, T; Morio, R; Sasaki, T, 2014) |
| "We report a case of fatal acute pancreatitis caused by severe hypertriglyceridaemia in a 27-year-old male who was treated with quetiapine." | ( Abed, OK; Andos, S; Lindberg, M, 2014) |
| "In severe acute pancreatitis, the administration of fluids in the presence of positive fluid responsiveness is associated with better outcome when compared to guiding therapy on central venous pressure." | ( Bachmann, KA; Bonk, S; Gocht, A; Goetz, AE; Havel, J; Heckel, K; Izbicki, JR; Lena, T; Mann, O; Poppe, AM; Reuter, DA; Saugel, B; Strobel, CM; Tomkötter, L; Trepte, CJ; Wodack, KH, 2014) |
| "In rats with acute pancreatitis, pretreatment with secretin aggravated the disease, but ANF prevented secretin-induced changes." | ( Bianciotti, LG; Carozzo, A; Davio, CA; Najenson, AC; Perazzo, JC; Vatta, MS; Ventimiglia, MS, 2015) |
| "Adult patients with acute pancreatitis were randomized to standard therapy or standard therapy plus lornoxicam." | ( Agapov, MA; Gorsky, VA; Khoreva, MV; Leonenko, IV, 2015) |
| "For a better survival of severe acute pancreatitis, the treatment should focus on an improvement of pancreatic microcirculation." | ( Bachmann, K; Bockhorn, M; Dupree, A; Erbes, J; Hinsch, A; Izbicki, JR; Mann, O; Tomkötter, L; Trepte, C, 2016) |
| "To replicate human acute pancreatitis with hamsters, we comparatively studied the efficacy of common methods, such as the peritoneal injections of caerulein, L-arginine, the retrograde infusion of sodium taurocholate, and another novel model with concomitant administration of ethanol and fatty acid." | ( Chen, L; Huang, S; Kayoumu, A; Li, W; Liu, G; Lu, G; Qi, R; Qiu, X; Wang, Y; Xu, P, 2016) |
| "We evaluated the incidence of acute pancreatitis and pancreatic cancer in patients with type 2 diabetes and cardiovascular disease who were treated with sitagliptin, a dipeptidyl peptidase-4 inhibitor (DPP-4i)." | ( Aschner, P; Bethel, MA; Buse, JB; Engel, SS; Grado, CR; Green, JB; Holman, RR; Josse, R; Lachin, JM; Lokhnygina, Y; Patel, K; Peterson, ED; Stevens, SR; Tankova, T; Wainstein, J, 2017) |
| "The incidence of acute pancreatitis was significantly increased in the gliptin-treated patients when compared with the control groups (odds ratio 1." | ( Raz, I; Tkáč, I, 2017) |
| "To assess the risk of acute pancreatitis during treatment with glucagon-like peptide 1 receptor agonist dulaglutide, placebo, and active comparators across phase 2/3 dulaglutide trials." | ( Anglin, G; Barkin, JS; Frossard, JL; Harper, KD; Hensley, IE; Milicevic, Z; Nauck, MA, 2017) |
| "The exposure-adjusted incidence rate of acute pancreatitis in dulaglutide-treated patients was similar to the rates with placebo, with few reported cases during the entire program." | ( Anglin, G; Barkin, JS; Frossard, JL; Harper, KD; Hensley, IE; Milicevic, Z; Nauck, MA, 2017) |
| "As about a quarter of people with acute pancreatitis fail to be diagnosed as having acute pancreatitis with the evaluated tests, one should have a low threshold to admit the patient and treat them for acute pancreatitis if the symptoms are suggestive of acute pancreatitis, even if these tests are normal." | ( Davidson, BR; Gurusamy, KS; Hann, A; Komolafe, O; Pereira, SP; Rompianesi, G, 2017) |
| "Effect of morphine treatment on acute pancreatitis in caerulein, L-arginine and ethanol-palmitoleic acid models was evaluated after induction of the disease." | ( Banerjee, S; Barlass, U; Cheema, H; Dawra, RK; Dixit, A; Dudeja, V; Dutta, R; George, J; Giri, B; Meng, J; Roy, S; Saluja, AK; Sareen, A; Yuan, Z, 2018) |
| "Although several treatments of acute pancreatitis have been developed, some patients have been resistant to current therapy." | ( Nishihira, J; Ohkawara, T; Takeda, H, 2017) |
| "Furthermore, in an in vivo study using acute pancreatitis model mice as a model of an inflammatory disease, a CO-HbV treatment also tended to polarize macrophages toward an M2-like phenotype and inhibited neutrophil infiltration in the pancreas, resulting in a significant inflammation." | ( Maeda, H; Maruyama, T; Nagao, S; Otagiri, M; Sakai, H; Taguchi, K; Wakayama, T; Watanabe, H; Yamasaki, K; Yanagisawa, H, 2018) |
| "Early identification of severe acute pancreatitis is important for early stratification, goal directed fluid therapy, rationalizing level of care to improve outcome." | ( Bohara, TP; Joshi, MR; Laudari, U; Parajuli, A; Rupakheti, S, 2018) |
| "Cognitive impairments induced by severe acute pancreatitis (SAP) are severe complications, for which there are a lack of effective pharmacological treatment strategies." | ( Gong, C; Hua, Y; Kang, Y; Liao, X; Ou, X, 2018) |
| "Hence, patient was diagnosed with mild acute pancreatitis that was treated with aggressive intravenous (IV) hydration and pain management with bowel rest of 2 days duration and significant improvement being noticed within 72 h." | ( Chams, S; El Sayegh, S; Hamdon, M; Kumar, S; Tegeltija, V, 2018) |
| "The patient, who was diagnosed with acute pancreatitis 4 months after initiating linagliptin 5 mg/d treatment, was admitted to our hospital." | ( Kayhan, B; Ozkan, AE; Sevencan, NO, 2018) |
| "Furthermore, it has been suggested that acute pancreatitis is a potential complication of liraglutide therapy and liraglutide should be used cautiously in patients at risk of pancreatitis." | ( Quesada-Vázquez, N, 2019) |
| "Incident acute pancreatitis (physician-assigned diagnosis with ICD-10 code K85) occurring in the 90 days following treatment initiation were identified through outpatient and inpatient hospital records." | ( Ludvigsson, JF; Melbye, M; Olén, O; Pasternak, B; Svanström, H; Wintzell, V, 2019) |
| "The risk of acute pancreatitis needs to be considered when deciding on optimal treatment strategies." | ( Ludvigsson, JF; Melbye, M; Olén, O; Pasternak, B; Svanström, H; Wintzell, V, 2019) |
| "Dogs with acute pancreatitis received treatment either with dose of 1 mg/kg/day prednisolone (n=45) or without prednisolone (n=20)." | ( Nagata, T; Nakane, S; Okanishi, H; Watari, T, 2019) |
| "In dogs with acute pancreatitis, initial treatment with prednisolone resulted in earlier reductions in C-reactive protein concentration and earlier improvement of clinical signs." | ( Nagata, T; Nakane, S; Okanishi, H; Watari, T, 2019) |
| "Although acute pancreatitis is rare it is clinically important because this condition can be life threatening if not treated promptly." | ( Li, YF; Wei, MJ, 2019) |
| "The treatment and prognosis for severe acute pancreatitis (SAP) is currently unsatisfactory showing a high incidence of morbidity and mortality." | ( Liu, D; Ma, Z; Meng, H; Qian, D; Song, G; Song, Z; Zhou, B; Zhou, J, 2019) |
| "Calcium overload in the early stage of acute pancreatitis was previously found to cause intracellular trypsinogen activation; however, treatment of acute pancreatitis using calcium channel blockers did not produced consistent results." | ( Jin, J; Lin, H; Liu, B; Xiao, J, 2019) |
| "No specific therapy exists for acute pancreatitis (AP), and current treatment remains entirely supportive." | ( Cook, TG; Maatman, TK; March, KL; Merfeld-Clauss, S; Roch, AM; Traktuev, DO; Wu, HH; Zyromski, NJ, 2020) |
| "Recent international guidelines for acute pancreatitis (AP) recommend limiting anti-infective therapy (AIT) to cases of suspected necrotizing AP or nosocomial extrapancreatic infection." | ( Constantin, JM; Dupont, H; Jabaudon, M; Kantor, E; Lefrant, JY; Lescot, T; Montravers, P; Nesseler, N; Paugam, C, 2019) |
| "In vitro acute pancreatitis was induced by treatment with a supramaximal dose of cerulein." | ( Kim, JO; Paik, K; Park, WS; Yang, KJ, 2020) |
| "The link of acute pancreatitis (AP) with Incretin based therapies (IBTs) in type 2 diabetes has existed since United States Food and Drug Administration alert in 2010." | ( Gangopadhyay, KK; Singh, AK; Singh, R, 2020) |
| "Patients with acute pancreatitis are frequently treated with opioids, but their risk for ongoing use is not well known." | ( Ahmed, A; Freedman, SD; Kothari, DJ; Sheth, SG; Yakah, W, 2020) |
| "Opioid analgesics treatment in acute pancreatitis is associated with severity, complications and mortality, while advanced age increases the risk of systemic complications." | ( Jankovic, S; Matic, S; Natasa, D; Radosavljevic, I, 2021) |
| "In the past 10 years, treatment of acute pancreatitis has moved towards a multidisciplinary, tailored, and minimally invasive approach." | ( Besselink, MG; Boermeester, MA; Bouwense, SA; Boxhoorn, L; Bruno, MJ; van Santvoort, HC; Verdonk, RC; Voermans, RP, 2020) |
| "WE is a rare adverse event during acute pancreatitis therapy." | ( Ji, L; Jiang, Y, 2020) |
| "The relationship between acute pancreatitis and the administration of glucocorticoids is unclear because most reported cases have been diagnosed with systemic vascular diseases, such as systemic lupus erythematosus, which may be responsible for pancreatitis." | ( Akpınar, G; Atıcı, SD; Engin, Ö; Tuğmen, C, 2020) |
| "Drug-induced acute pancreatitis (DIAP) is an often-neglected entity where the disorder is the consequence of the toxic effects of various agents applied to treat potentially life-threatening conditions, such as inflammatory bowel disease." | ( Bajor, J; Faluhelyi, N; Hegyi, P; Hegyi, PJ; Németh, BC; Szakács, Z, 2020) |
| "In the caerulein-induced mild acute pancreatitis (MAP) model, We found that AS administration reduced serum amylase levels and alleviated the histopathological manifestations of pancreatic tissue in a dose-dependent manner." | ( Ding, Y; Gong, W; Hu, L; Liu, X; Lu, G; Shi, X; Wu, K; Yang, Q; Yao, G; Zhang, H; Zhu, Q, 2021) |
| "We report a case of acute pancreatitis that developed after four days of remdesivir therapy in a patient being treated for COVID-19." | ( Khadka, S; Solanki, S; Williams, K, 2022) |
| "Symptoms associated with acute pancreatitis can be debilitating, and treatment remains a challenge." | ( Damon, M; Dixon, KJ; Randhi, R, 2021) |
| "In addition, ovariectomy changed select acute pancreatitis responses that were only partially rescued by estradiol pre-treatment." | ( Gorelick, F; Wang, M, 2022) |
| "The pathogenesis of acute pancreatitis (AP) initiation and progression is still unknown, and effective treatment is limited to supportive care." | ( Bulak, K; Fichna, J; Talar, M; Tarasiuk, A, 2021) |
| "The patient was treated for acute pancreatitis." | ( Sütcüoğlu, O; Unsal, O; Yazıcı, O, 2022) |
| "Moderate to severe acute pancreatitis (AP) is associated with a high rate of complications and increased mortality, yet no targeted pharmacologic treatment currently exists." | ( Cook, ME; Drewes, AM; Fjelsted, CA; Frøkjær, JB; Hansen, MB; Knoph, CS; Mortensen, MB; Nielsen, LBJ; Novovic, S; Olesen, SS, 2021) |
| "MiR-325-3p inhibits acute pancreatitis by targeting RIPK3-dependent necroptosis, which may represent a novel treatment method for acute pancreatitis." | ( Cui, YF; Jia, A; Liu, JM; Shi, JY; Yang, ZW; Zhang, K, 2022) |
| "In the caerulein-induced mild acute pancreatitis (MAP) model, we found that Pae administration reduced serum levels of amylase, lipase, IL-1β and IL-6 and alleviated the histopathological manifestations of pancreatic tissue in a dose-dependent manner." | ( Chen, W; Ding, Y; Gong, W; Lu, G; Pan, J; Wang, N; Wu, K; Xiao, W; Xu, X; Yao, G; Yuan, C; Zhang, J; Zhu, Q, 2022) |
| "The onset of acute pancreatitis and increased pancreatic enzyme levels and clinical, laboratory, treatment, and outcome data were collected and analyzed." | ( Aga, M; Agemi, Y; Hamakawa, Y; Misumi, Y; Miyata, N; Miyazaki, K; Okamoto, H; Sasaki, H; Shiba, A; Shimokawa, T; Tachikawa, N; Taniguchi, Y; Yoshimura, Y, 2022) |
| "We hereby delineate a rare case of acute pancreatitis secondary to hypertriglyceridemia in a patient who was on tamoxifen treatment for the past 3 years." | ( Abbasi, EUH; Amin, MK; Ashraf, MJ; Goraya, MHN; Hussain, N; Inayat, F; Malik, A; Nawaz, G; Qayyum, M; Zaman, MA, 2023) |
| "This article illustrates that acute pancreatitis should be considered in the differential diagnoses of abdominal pain and elevated pancreatic enzymes in patients undergoing tamoxifen treatment." | ( Abbasi, EUH; Amin, MK; Ashraf, MJ; Goraya, MHN; Hussain, N; Inayat, F; Malik, A; Nawaz, G; Qayyum, M; Zaman, MA, 2023) |
| "Severe cases of acute pancreatitis are potentially fatal and have no specific treatment available." | ( Fang, Q; Xiao, J; Zeng, W; Zhang, P; Zhou, Y, 2022) |
| "No patient experienced acute pancreatitis or severe abdominal pain during lomitapide treatment." | ( Arca, M; Averna, M; Barbagallo, CM; Caldarella, R; Cefalù, AB; Ciaccio, M; D'Erasmo, L; Forte, F; Ganci, A; Giammanco, A; Giannini, S; Iannuzzo, G; Montali, A; Nardi, E; Noto, D; Suppressa, P; Vernuccio, F; Zambon, A, 2022) |
| "Patients with mild and moderately severe acute pancreatitis can be treated effectively with INS safely and effectively without HP." | ( Chen, LC; Lin, XY; Lin, ZH; Ye, ZS; Zeng, Y; Zhang, ZC, 2022) |
| "Thiopurine-induced acute pancreatitis (TIP) is one of the most common adverse events among inflammatory bowel disease patients treated with azathioprine (AZA), representing a significant clinical burden." | ( Bagyánszki, M; Bódi, N; Crul, T; Görög, M; Hegyi, P; Kis, A; Maléth, J; Pallagi, P; Papp, N; Sendstad, IH; Susánszki, P; Szabó, V; Tél, B; Varga, Á, 2023) |
| "However, research in treating acute pancreatitis with neostigmine is currently limited." | ( Du, T; Sheng, Y; Sun, H; Zhu, H, 2023) |
| "Pain is the most common symptom of acute pancreatitis (AP), and opioids have been utilized as the cornerstone of treatment." | ( Abu-El-Haija, M; Gorbounova, I; Palermo, TM; Tham, SW, 2023) |
| "Moreover, in a mouse model of acute pancreatitis that is associated with necroptosis, celastrol administration significantly reduced the severity of caerulein-induced acute pancreatitis accompanied by decreased phosphorylation of MLKL in pancreatic tissues." | ( Chen, SY; He, XH; Hu, B; Li, YP; Liang, QQ; Ouyang, DY; Shi, ZJ; Xu, LH; Xu, R; You, YP; Yuan, T; Zha, QB; Zhang, HR, 2023) |
| "VPA-induced acute pancreatitis was diagnosed, VPA was discontinued, and high-dose infusions were administered." | ( Harada, M; Hashimoto, R; Igata, R; Ikenouchi, A; Isomoto, N; Konishi, Y; Okamoto, N; Shinkai, T; Yanaga, M; Yoshimura, R, 2023) |
| "With the number of patients with acute pancreatitis (AP) increasing year by year, it is pressing to explore new key genes and markers for the treatment of AP." | ( Chen, C; Wu, Z; Yu, X; Zhan, Y; Zhou, F, 2023) |
| "We describe a case of acute pancreatitis (AP) and hypofibrinogenemia associated with drug treatment with the aim to increase awareness of uncommon yet possibly life-threatening adverse reactions of tigecycline and furosemide." | ( Li, ZK; Zheng, P, 2023) |
| "Severe acute pancreatitis (SAP) is a common critical disease of the digestive system, with high mortality and a lack of effective prevention and treatment measures." | ( Hu, Z; Hua, J; Luo, T; Ma, Z; Shi, S; Song, Z; Wang, W; Xie, W; Xu, J; Yang, T; Yu, X; Zhou, J, 2023) |